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The Mountain Gorillas of Central Africa are one of the most highly endangered
species in the world, with only 740 individuals surviving. One of the greatest threats to this
species is disease. Health of wildlife is continually garnering more attention in the public
arena due to recent outbreaks of diseases such as West Nile and High Pathogenic Avian
Influenza. However, no system currently exists to facilitate the management and analysis of
wildlife health data. The research conducted herein was the development and testing of a
health information monitoring system for the mountain gorillas entitled Internet-supported
Management Program to Assist Conservation Technologies or IMPACT™. The system
functions around a species database of known or unknown individuals and provides
individual-based and population-based epidemiological analysis. The system also uses
spatial locations of individuals or samples to link multiple species together based on spatial
proximity for inter-species comparisons. A syndromic surveillance system or clinical
decision tree was developed to collect standardized data to better understand the ecology of

diseases within the gorilla population. The system is hierarchical in nature, using trackers
and guides to conduct daily observations while specially trained veterinarians are used to
confirm and assess any abnormalities detected. Assessment of the decision tree indicated
that trackers and guides did not observe gorilla groups or individuals within groups
similarly. Data suggests that, to be consistent, trackers and guides need to conduct
observations even on the day that veterinarians collect data. Validity and reliability remain
to be tested in the observation instrument. Assessment of pathogen loads and distributions
within species surrounding the gorillas indicates that humans have the greatest pathogen
loads with 13 species, followed by cattle and chimpanzees (11), baboon (10), gorillas (9),
and rodents (3). Spatial aggregation occurred in Cryptosporidium, Giardia, and Trichuris;
however, there is reason to question the test results of the former 2 species. These data
suggest that researchers need to examine the impact of local human and domestic animal
populations on gorillas and other wildlife.
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CHAPTER I
THEORETICAL DEVELOPMENT OF AN OBSERVATIONAL HEALTH
MONITORING INFORMATION SYSTEM FOR THE
MOUNTAIN GORILLA (GORILLA BERINGEI)

ABSTRACT
Traditional wildlife management focuses on health and management of the
population as a whole. At extremely low population levels, however, an individual
within the population comprises a relatively large proportion of the total genome and
conservation of every individual is important to maintain genetic integrity of the
population. Although individuals become a focus in these endangered species, the
population-level processes must still be observed and managed. To adequately
manage a species with a critically low population level, conservationists and resource
managers must place equal emphasis on the status of the individual and the
population. Mountain gorillas are a critically endangered species with only 740
individuals remaining in 2 extant populations. Every individual gorilla is of
tremendous conservation value. Since the inception of Mountain Gorilla Veterinary
Project (MGVP) in 1986, data have been collected to facilitate prevention and treatment
of disease and injury in mountain gorillas. Additionally, data are being collected on
humans and other nonhuman animals in and around the region occupied by the gorillas.
1

Past research suggests that pathogens are being shared among species sympatric with the
gorillas. Although research suggests the potential sharing of pathogens, data from
different projects cannot, at the current time, be integrated to test these hypotheses.
Much of the data are maintained by individual researchers rather than the funding
agency or any coordinating agency. Consequently, 17 years worth of gorilla health data
exist, but not in a format that can be used in a cohesive analysis to examine the
potentially devastating impacts of pathogens in the ecosystem and on the gorilla
population. This project developed a web-based computer information system called
IMPACT that will; 1) integrate existing data into a consistent, spatially explicit,
compatible format, 2) provide a template to guide future data collection in a consistent
fashion, and 3) facilitate data coordination and analysis across a diverse array of
projects. An integrated, spatially explicit, computerized information system
incorporating standardized definitions, standardized data fields, regular reporting,
standardized analysis routines and routine output generation, with access capability from
many parts of the world aid MGVP and other great ape researchers in long-term
maintenance of primate populations.
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INTRODUCTION
The five species of great apes, the Orangutans (Pongo pygmaeus) of Borneo and
Sumatra, and the chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas
of Africa are facing uncertain futures with their long-term sustainability in question
(Butynski 2001). The most prominent threat to their survival is habitat destruction and
fragmentation from logging and agricultural activities. The second most serious threat
relates to the development of roads associated with logging, allowing access and
transport to and from remote areas providing an infrastructure for a commercial bush
meat industry. Disease is ranked the third highest threat, and has risen in public
awareness due to the highly publicized outbreaks of Ebola virus in western Africa with
resulting high mortalities in chimpanzees and gorillas. In protected areas (i.e.,
conservation areas and national parks) where deforestation and bush meat practices are a
lesser threat, disease is rated as the premier threat.
In 1998, the Population Habitat Viability Assessment Workshop held by the
Captive Breeding Specialist Group in Uganda (CBSG 1997) identified disease
introduction as the highest risk to the sustainability of the two populations of mountain
gorillas (Gorilla beringei beringei) in the protected areas of the Virunga Massif and
Bwindi Impenetrable Forest National Park (Werikhe and Miller 1998). These parks
have sharp boundaries between the forest and the human communities, with few existing
buffer zones. The human communities around the mountain gorilla parks have a density
of between 423-538 people/km2 (2002 Rwanda Census, Office National de la
Population [ONAPO], Revue du Rwanda sur population et development, No 38, June
2003) and a population growth rate of approximately 3.7%/year (Butynski 2001). The
3

mountain gorilla populations have the greatest number of habituated individuals of any
ape species and are subjected to intense research and ecotourism programs. These
factors, compounded by agricultural practices at the boundaries of the park, promote
exposure between gorillas, humans, and domestic animals, thus, increasing the risk of
disease transmission. The health care within the human and domestic animal
populations is less then optimal and poor sanitation is common. Genetic research has
shown that the same species of enteric organisms (Giardia spp., Microsporidea spp. and
Cryptosporidea spp.) are circulating amongst humans, cattle, and gorillas (Nizeyi et al.
1999, 2000, 2002). The prevalence of antibiotic resistance to Enterococcus sp. and E.
coli is greater than expected in a naïve wildlife population and has a similar pattern to
human and cattle antibiotic resistance. Gorillas share approximately 97-98% genetic
similarity (Sibley and Ahlquist 1984, Hacia 2001) with humans and are susceptible to
many of the diseases associated with humans, including the zoonotic diseases of
livestock. Opportunistic blood samples have shown that the gorillas are naïve to many
of the diseases of the region (i.e., measles) that can cause high morbidity and mortality
and therefore gorillas are a high risk population for a serious epidemic (Hastings et al.
1991). This concern of disease transmission exists within all great ape research
communities.
In the 1997 Uganda Population and Habitat Viability Assessment Workshop,
participants concluded that “presently, there is no effective mechanism of orderly,
standardized collection, management and dissemination of data and materials relevant to
mountain gorilla health.” The recommendation was to “establish an interactive,
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international computerized database” providing epidemiological data as the basis for
developing policies on mountain gorilla health.
The Mountain Gorilla Veterinary Project (MGVP), supported by the Morris
Animal Foundation, was formed in 1986 at the request of Dian Fossey to provide
emergency medicine and pathology services to the Mountain Gorilla Population of
Rwanda (Cranfield et al. 2002). Due to low numbers of gorillas in these populations,
and genetic studies showing that each animal's genetic input into the population's
genome is important, mountain gorillas are managed on an individual as well as a
population basis with respect to veterinary care (Cranfield et al. 2002).
In a MGVP Strategic Planning Workshop in 2000, participants identified
MGVP’s vision to be “the premier research and health monitoring resource for
achieving self-sustaining mountain gorilla populations.” The mission of MGVP as
agreed by project participants was to improve the sustainability of the mountain gorillas
by 1) monitoring the health of gorilla populations, 2) providing health care, 3)
conducting relevant health studies and 4) disseminating information (Cranfield et al.
2000). Additionally, “the goals and strategies to enhance the research program were
determined, reviewed and then prioritized over three days by the group. The areas of
enhancement were: 1) monitor, evaluate, and coordinate the Mountain Gorilla
Veterinary Project research program, 2) improve the biological database and
preventative medicine program, 3) expand species focus to include other great apes, the
health of the local human community, and specific problems of other species which
impact the mountain gorilla populations, and 4) improve dissemination of research
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findings and health information from the Mountain Gorilla Veterinary Project’s research
program, as well as other research relating to mountain gorilla health.”
The need to better handle biological data for the benefit of wildlife health is not
unique to MGVP. In 2004, many of the world’s leading great ape health researchers met
in Leipzig, Germany to discuss the issue of health management. From this meeting, the
Great Ape Health Monitoring Unit (GAHMU) was formed. The excerpt below is taken
directly from the GAHMU web site at
http://www.eva.mpg.de/primat/GAHMU/index.htm and explains the mission of
GAHMU.
The Great Ape Health Monitoring Unit (GAHMU) is a network of researchers
from different disciplines concerned about diseases of great apes.
Even though diseases among wild living great apes under human observation
have been observed by many field workers, detailed information and
descriptions of first-hand experiences are rarely published or distributed thinly
among journals with widely disparate academic audiences. For far too long, the
focus of great ape behaviour researchers, ecologists and conservationists has
been separated from the one followed by scientists working in the field of great
ape medical sciences. Today, due partly to severe health problems in great apes
populations in the wild (Ebola, measles, polio and unexplained cases of death),
more scientists are calling for a connection between these fields.
A major limitation to progress is the insufficient knowledge about infectious
diseases and transmission of pathogens in wild great apes. An interdisciplinary
approach could help to expand the knowledge base for protecting the health of
great ape populations, with recent Ebola and other outbreaks among great ape
populations demonstrating that diseases must also be considered a major threat,
it should provide information about risks of emerging infectious diseases to
humans and could also help in the understanding of disease evolution and its
impact on primate evolution.
GAHMU will aid in this progress by providing drafts for health care plans,
outbreak protocols, and by promoting the development and use of new, noninvasive methods of monitoring the health of wild great apes, and in cases of
death, effective methods to identify the causative pathogens.

6

We are currently engaged in two concrete projects:
a) Creating a “Great Ape Task Force”, an emergency group of experienced
veterinarians to support field sites when great apes are showing sever(e) [SIC]
symptoms or cases of deaths are observed.
b) Obtaining data on pathogens of different great ape populations. Different
laboratories will screen non-invasive samples for a set of pathogens. This study
involves a number of great ape field-sites, and additional data will be obtained
there to analyze the effect of parameters like climate, inter-species contact or
environmental disruption on disease transmission.
Health monitoring involves the systematic collection and evaluation of general
health data which can lead to detection of disease at earlier stages when life saving care
can more easily and effectively be provided. Disease surveillance, the complement of
health monitoring, has been defined as the continuing scrutiny of all aspects of
occurrence and spread of disease pertinent to effective control (Thrushfield 1995). Early
detection and management of disease to minimize negative impacts on the population is
the goal of disease surveillance. Types of data that are systematically collected and
evaluated as part of disease surveillance include: morbidity and mortality reports, reports
of field investigations of epidemics, individual case reports, vaccination and population
immunity data, and any other relevant epidemiologic data (Last et. al. 2000). For the
mountain gorilla, much of this comes from post-mortem pathology reports,
parasitology/bacteriology studies, and veterinary field notes.
Although non-invasive samples can be collected regularly (feces, urine, and
hair), they provide only a limited amount of information about disease status. Other
samples, such as blood, tissue, etc., that could provide more diagnostic information,
require direct physical contact. Currently, generally accepted intervention policies
dictate that physical contact interventions only occur in the case of human-induced
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injury (e.g. snares, and gunshot wounds) or life-threatening disease, therefore only
immobilized moribund gorillas or gorilla carcasses provide more diagnostic sample
material. Although these samples provide important information to fill in gaps in the
epidemiologic profile, sampling is opportunistic. With only opportunistic access to
blood and tissue samples due to the strict non-intervention policy, understanding of
newly introduced pathogens and the epidemiological profile of wild gorillas has been
limited.
The science of epidemiology is well developed and effective tools exist to assist
in providing a scientific assessment of the health risks of mountain gorillas. To date,
however, these tools have not been applied adequately. A key tool in effective
epidemiological investigation to assess mountain gorilla populations is information
technology; specifically well-designed information or expert systems that can be
manipulated to answer questions important to disease control and health management
(Adelman 1992). Information technology and information management is also vital to
the practice of modern medicine (Shortliffe et al. 2001). An integrated computerized
information system incorporating standardized definitions, standardized data fields,
regular reporting, standardized analysis routines and routine output generation, with
access capability from many parts of the world will aid MGVP and other great ape
researchers in long-term maintenance of primate populations.

OBJECTIVES
This project will test the general hypothesis that data collected as part of
MGVP’s routine project activities, coupled with select special studies, can be organized
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and processed to provide information relevant for program management, policy making,
and conservation for great ape species. Specific objectives are:
1) Develop the theoretical framework for a health monitoring system for freeranging wildlife species called IMPACT (Internet-supported Management
Program to Assist Conservation Technologies),
2) Construct, document, and verify the observation components of the system,
3) Evaluate the effectiveness of IMPACT to integrate disparate research and
monitoring data into standardized information that, collectively, can provide
constantly updated baseline denominator data for epidemiological analysis and
disease outbreak monitoring,
4) Evaluate the effectiveness of IMPACT to integrate multiple species
information into an interspecific disease risk assessment analysis, and
5) Develop a framework for testing the effectiveness of IMPACT to calculate
epidemiological thresholds, increase detection rates of outbreaks, and reduce
mortality and morbidity of disease.

APPROACH
Development of any information system requires a logical step-by-step approach
to ensure consistency, applicability, and functionality (Adelman 1992). The
development of the IMPACT health management information system will use an 8 step
process to ensure all of these.
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Step #1: Database function
The first step in development is to understand the ecological and
epidemiological problems associated with mountain gorilla conservation and identify the
questions that can be addressed by clinical observations organized in a cogent database.
What are the objectives we want to achieve with the data? Specifically; we are
interested in standardized data collection of gorilla and other species health data for
long-term intra- and interspecies comparison. What specific health questions are we
asking, such as what is the annual, seasonal, gender or age-based prevalence of clinical
signs in mountain gorillas? What data are available and what is the spatial distribution
of the data? Should the system be able to work on more than one species? How can we
make the system be multi-species capable, but still retain the objectives of analyzing
gorilla health? The MGVP team has been working for numerous years to formulate the
questions, as well as, the answers. Additional questions have been raised by the 1997
Uganda Population and Habitat Viability Assessment Workshop and the newly formed
GAHMU. Undoubtedly, even more questions will be raised as data are collected in a
consistent format and analyzed.

Step #2: Overall system design and integration
The next step in development is the understanding of the design and integration
of the whole information system. Similar to above, we have to ask questions such as:
what is the format and scope of the existing data? How do existing data sets that are
meant to examine different aspects of gorilla health function together; if at all? What
will be the format of the data that will be collected in the future? How can we integrate
10

the “old” data and the “new” data in the future and still answer the questions from step
#1 above? Figure 1.1 illustrates a pictorial diagram of existing data (shown as groupings
or datasets) from MGVP that are currently collected to monitor for gorilla health.
Figure 1.1a illustrates how much association exists between the different datasets and/or
current availability of these data for use. Figure 1.1b illustrates the potential expansion
of usable information that could be gained from the integration of information.
During this process, thought needs to be invested into how datasets function
together in a single system. Detailed analysis of the system needs to be undertaken at
this point to identify relationships between data sets. A relational database management
system or RDMS, in a simplified form, is a series of tabular information that can link
together through a single or series of common fields or identifiers. Figure 1.2 illustrates
how much of the existing data can function together in a relational system with
identifiers of an individual of a species being the link among the data. A well developed
relational database system is extremely flexible and very powerful in terms of
integrating and analyzing data from many different sources. The process of developing a
RDMS requires that data entered into the system be in a standardized format. This will
ensure consistency and comparability of data. Once standards of data collection are
established, the system can continue to grow with the addition of new data components
or datasets in the future. Data dictionaries that define the variables required for input are
needed to ensure data collection quality once standards are developed and implemented.
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Step #3: Compartmentalize the system
Figure 1.2 illustrates the complexity inherent in a multi-faceted information
system. To attempt to build such a system in a single pass would ensure errors and
problems. Thus, the system should be divided into components (Figure 1.1).
Components are more manageable than the whole system, and if the associations among
components (Figure 1.2) are considered, they are simply modules that can be easily
combined together at a later date. This also allows for future expansion of the system in
an easy manner. Components addressed in this research include a syndromic
observation component and a specimen collection and test result component. Other
components include, employee health data, necropsy data, tourist health data, and
monitoring data for domestic and wild animals within and around the gorilla parks.
Figures 1.1 and 1.2 illustrate how the system can be developed to be species
centric and function for any species of concern. For any species, many of the
components are going to be the same. Samples will be taken, test results provided,
observation made, locations recorded, etc. Thus, a system that uses a species database
as the central hub can have any of the individual components added or removed as
needed as long as development follows the integration shown in Figure 1.2. This
provides flexibility in application to numerous wildlife species.

Step #4: Component development
This is the most crucial portion of this system. If each component is not
developed regarding linkages with other components, the system will not function
correctly. Additionally, this is the largest portion of the system development in terms of
12

time and labor. Although development and refinement is listed as step 4 in the overall
process, it also occurs during steps 5-7. To understand the methods of development,
focus will be on the specimen collection and test results component as an example.
Specimens are being collected by great ape researchers in the field on a continual
basis. These specimens include, but are not limited to, fecal, blood, parasite, and other
tissue samples. Specimens are unique to an individual animal whose identity may or
may not be known and the sample was collected at a unique and known georeferenced
location and time. Samples are collected and labeled in the field and stored for analysis.
Most studies, in general, adhere to the following protocol with samples. Sample
information is usually entered into some electronic format for storage. Specimens are
sent to a laboratory where test results are generated and associated with the specimen.
These test result data are then entered into electronic format, usually the same
information file where the original sample information was entered.
Often, however, samples are collected for the purpose of analysis sometime in
the future. These samples, as well as the others, need to be clearly marked with enough
identifying information to uniquely identify them among all other potential samples.
The specimen data can be entered into electronic format where a unique identifier can be
developed. The issue in this case, is the uniqueness of the identifier for the specimen.
Test results can be added to the original specimen data at any later date simply by using
the unique identifier as the linking variable.
For this process to function, several steps need to occur. First, the database
structure for each aspect of the component should be developed. A database must be
developed to maintain information on the specimen collected, then a database must be
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developed to maintain information on the results from test run on the specimen, and both
databases must be able to be linked back to an individual (known or not) and a spatial
location. Specimens collected in the field need to be marked, minimally with the
following information: date of collection, initials of collector, specimen type, specimen
species, individual from which it was collected (if known), and location where the
sample was taken. The information regarding the specimen is entered into the system
where a unique identifier is developed either from the information on the specimen, or
through an automatic numbering system. This unique identifier is recorded on the
specimen for future identification.
Several factors need to be considered when the database is constructed to
accommodate these data. Fields in the database need to be standardized for the system
to work properly. These standards include such simple issues as how the date should be
recorded and entered and complex issues such as how do several subsamples or aliquots
of the same item (i.e. multiple samples from the same feces) get recorded and
differentiated. Standard data entry forms need to be developed to ensure consistency in
collection and promote ease of entry of data into the system. With this step, issues of
data analysis need to be considered. Do the data need to be numeric with look-up tables
for identifiers, or can categorical text information be used? What are the possible
values, range, format, etc. that will be allowed for entry? This aspect needs to be
examined closely so as to ensure flexibility or rigidity of use. Establishing domains
within fields forces researchers to label data in a standard manner. This helps to ensure
cleanliness of data and limits the amount of data cleaning required at a later date.
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The final step in this phase is the development and testing of data queries and
algorithms. Data are of no value if they cannot be accessed efficiently. The system
should be programmed to have pre-defined queries of the data that are commonly run,
and allow for new queries to be developed.

Step #5: Incorporation of existing data
Considerable amounts of data have been collected by MGVP field personnel in
the past (Figure 1.1), however, much of these data are not in a usable form. Those data
that are available and accessible (some original datasets have been lost over time) will
be compiled and incorporated into the new components in Step #4 above. This stage
will be variable in the amount of work needed to get different data sets into the system.
Data existing in electronic format can either be directly imported, or copied into the
system after reformatting of the data into a standard defined by the IMPACT system.
Data from previous MGVP research will be the primary source to initially populate the
databases. Researchers from these previous studies will be contacted and the data
requested through MGVP.
This process will allow for evaluation of the database structure, entry forms, and
domains of Step #4. Evaluation of the process from Step #4 above will be conducted
throughout this process. Alterations to the system will be a continuing facet of this
phase.
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Step #6: Creation of standardized data entry forms and data dictionaries
For multiple researchers to collect data that can be entered easily into a health
monitoring system, standardized data entry forms are required. Data collection forms
for each component of the system will be developed to provide the minimal information
required for monitoring. These forms should be available for use in several formats.
Basic paper forms should be available and electronic forms also should be available for
use on personal data assistants (PDAs).
PDA systems such as Palm OS® and PocketPC® systems are commonly being
used for data collection. Advantages of these systems include ease of use, ability to use
forms from step #4 above, reduction of data entry errors, automation of data collection,
speed of data transfer, and reduction in the need to maintain paper and paper trails.
Therefore, all data entry screens such as the specimen collection form will be ported to a
system that can be incorporated into PDAs. The PDAs can then be used in the field, and
data on specimens collected entered at the time of sampling. Disadvantages of these
systems are that they are electronic, requiring battery power and being susceptible to the
elements. Integrated GPS units on the systems will prevent errors in collecting
locational information. This helps prevent errors of date, time, etc. and can ensure the
generation of a unique sample number for each specimen taken. Once the researchers
return from the field, the data can be uploaded directly into the system. This will negate
the need for manual data entry at a later date and prevent data entry errors by third party
individuals not familiar with the data.
During this process, algorithms will be developed and tested to allow data
cleaning and screening at the time of data collection and uploading. This will ensure
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integrity of the data in the system. Algorithms will be developed to ensure that multiple
PDAs collecting data on the same day will maintain unique information.
Data dictionaries will be developed for each component and database of the
system. Dictionaries will define in detail the fields in each database, the structure of the
data, proper data collection methods, and limitations of the data.

Step #7: Web-based access
MGVP team members and gorilla researchers are stationed all across the globe.
This system would not be useful if it were contained in a single location with access
limited to that location. Therefore, the system will be developed to have access via the
World Wide Web. All forms for data entry will be accessible via the internet through a
secured, password-protected site. This will allow international access and ensure
protection of the data. With this system, researchers in Africa can upload data from their
PDAs while laboratory tests can be entered from Maryland, Mississippi, California, etc.
Additionally, this also will allow researchers across the globe to be able to access and
query the data at anytime. During this stage, the system will be devised to allow
multiple users simultaneous access. Conflict detection rules for multiple users as well as
data input rules will be developed to ensure data cleanliness.

Step #8: System integration
The final phase of development for IMPACT is to combine the individual
components developed in steps 4-7 above into a single integrated system. The
components should be able to be integrated seamlessly because they would be
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constructed containing the relationships developed in Step #2. This stage will require
replication of testing conducted in Step #4. The relationships of components will be
tested for efficiency and stability. Relationships will be indexed for speed of data query
and search.
This phase of the development will allow evaluation of objectives 2 and 3 above
related to integrating disparate datasets together for the purposes of health monitoring
and disease risk assessment. Specifically, data from a retrospective study of mountain
gorilla health being conducted by Lincoln Park Zoo can be integrated with the daily
monitoring of trackers and guides. Previous information regarding occurrence of
disease in mountain gorillas was based almost entirely on anecdotal data. The
retrospective study will give baseline information on the epidemiological profile of the
animals. There are problems with the retrospective data, however, in that the observers
only recorded abnormalities and not normalities. Thus, the combination of the
retrospective data with the daily observation data will allow a first assessment of
baseline data on epidemiological “normals” for this population. As more observation
data are entered these values should change. Specifically, the prevalence of
abnormalities within the population should drop significantly with the addition of the
observational data due to the biased nature of the retrospective data.
The system allows for the comparison of multiple species assemblages within
the same geographic location. To test this, several data sets from a 2002 study funded
by the U.S. Air Force that include human, gorilla, chimpanzee, baboon, cattle, and
rodents will be entered into the system. The overall pathogen load and prevalence of
specific shared pathogens will be evaluated based on the species occurring in spatial
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proximity to one another. This analysis will test the ability of IMPACT to work across
multiple species and examine test results from multiple fields in the data set. Nizeyi et
al. (1999, 2000, 2002) has shown that the same species of enteric organisms (Giardia
spp., Microsporidia spp. and Cryptosporidia spp.) are circulating among humans, cattle,
and gorillas in the Virunga Massif region.
The principal outcome of this research is a web-based system to monitor and
maintain information regarding health of free-ranging wildlife. The system will be the
backbone of a long-term health monitoring system for the mountain gorilla. Once the
system is fully functional, it will provide a framework to test the effectiveness of the
system to improve mountain gorilla health. Specifically, the system should reduce the
time necessary to detect of disease outbreaks, and allow for faster reaction time, thereby
reducing morbidity and mortality rates due to any specific disease. As data are entered
into the system, the thresholds at which a disease incident becomes an outbreak will be
defined. Additionally, while the system grows in data, it should refine these thresholds.
We will be able to define the number of cases that indicate outbreak on an annual,
seasonal, age-class, and gender basis. The thresholds will continue to be refined as
researchers use the system for outbreak detection and intervention.
The geospatial component of the system will allow ecologically-based questions
to be asked and potentially answered that could never before be addressed. Comparison
of infections by multiple pathogens to other vertebrate species within a spatial context
has not been conducted in any study to date. This new approach to assessing disease
concentration and spread could provide tremendous insight into the long-term
management of the isolated endangered species like the mountain gorilla.
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Because several organizations around the world have expressed great interest in
the system, it has the potential to become the building blocks for the Great Ape Health
Monitoring Unit. A single system that ensures the standardization and quality of data on
a long-term basis to aid in epidemiological and ecological assessments of health and
change in the ecosystem is a revolutionary concept to wildlife management. The fact
that numerous institutions working with different wildlife species are willing to put data
into a consistent format for data comparison is virtually unheard of, especially in the
great ape research community.
This dissertation outlines the development and testing of a health information
monitoring system for the mountain gorilla. This chapter introduced the conceptual
design of the system. Chapter 2 discusses the issues faced while constructing a system
designed to work in developed and developing countries. Chapter 3 outlines a
theoretical decision framework for use of observational data to detect, control, and
prevent disease outbreaks within the gorilla population. Chapter 4 provides an
assessment of the effectiveness of the decision framework of chapter 3 in terms of
implementation. Chapter 5 examines the spatial distribution of samples collected in past
studies and the pathogens detected within the samples. Chapter 6 provides a summary
of all the work completed in this project and lists the potential this work has on gorilla
and great ape conservation.
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CHAPTER II
PHYSICAL DEVELOPMENT OF AN OBSERVATIONAL HEALTH
MONITORING INFORMATION SYSTEM FOR THE MOUNTAIN GORILLA

ABSTRACT
The health of wildlife populations has received more and more attention over the
last 20 years. The expansion of human populations and the corresponding fragmentation
of the landscape have significantly altered the ecology and distribution of wildlife
diseases. Although researchers have been monitoring aspects of wildlife health for
years, no system has been developed to standardize the information captured or how the
data are integrated together. The Mountain Gorilla Veterinary Project has been
collecting health information on the endangered mountain gorilla (Gorilla beringei),
humans, livestock, and other wildlife species in Bwindi Impenetrable Forest National
Park and the Virunga Massif of central Africa for 19 years. A web-based syndromic
health monitoring system called IMPACT™ has been developed to collect and analyze
these data. The system is designed to facilitate individual and population level health
assessments. The system accepts known individuals (e.g., habituated gorillas and
humans) and unknown individuals (e.g., cattle and wild gorillas) to produce population
and individual level statistics. A spatial location allows users to conduct proximity
analysis across species to characterize elements of ecosystem health. Although the
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system was developed around the mountain gorilla, it has application for species in any
ecosystem. This chapter addresses the development of this health information system.
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INTRODUCTION
Alteration and fragmentation of landscapes on a global scale, coupled with
human population expansion has had significant effects on the ecology of wildlife and
wildlife diseases (Munson and Karesh 2002). The reduction in amount of available
habitat in ecosystems has caused greater interaction between wildlife and domestic
animals (Munson and Karesh 2002). Human expansion, along with the
accommodating livestock, also has increased the contact among these species. These
new interactions have allowed for the translocation of pathogens to new locations and
hosts (Wilson 2000).
Interest in the aspects of wildlife health and disease monitoring has increased
dramatically over the last 2 decades (Meffe 1999). Reasons for this burgeoning
interest in wildlife health include the effect that infectious and non-infectious diseases
have on wildlife, recent outbreak of diseases within the livestock and human
communities, and the general lack of information on diseases as it relates to recovery
of endangered species (Cooper 1998). Robust estimates of rates of infection, natural
levels of endemism of diseases and other baseline information on animal health does
not exist for most wild animals. Recent outbreaks of zoonotic diseases such as Ebola
(Morell 1995), monkey pox and Marburg, as well as, the recent issue of global
terrorism with biological weapons have increased the overall interest in this arena.
Although interest in wildlife disease issues would appear to be a relatively
new development, Leopold (1933) noted that “the role of disease in wildlife
conservation has probably been radically underestimated”. Similarly, a wildlife
health monitoring program was established in Sweden in 1945 due to the concern of
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landowners regarding death of wildlife species on their lands (Morner 2002).
Monitoring of toxicological impacts on wildlife is a well established discipline
(Carson 1962, Borg 1966). However, monitoring of diseases of wildlife has focused
on those pathogens that impact domestic livestock (Pastoret et al. 1988, Plowright
1988), were zoonotic (Friend 1976), or impacted economically important wildlife
species (Pearson and Cassidy 1997).
Great apes, the orangutans (Pongo pygmaeus) of Borneo and Sumatra, and the
chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas (Gorilla sp.) of
Africa are facing uncertain futures with their long-term sustainability in question
(Butynski 2001). The most prominent threat to their survival is habitat
destruction/fragmentation from logging and agricultural activities. The second most
serious threat relates to the development of roads associated with logging, allowing
access and transport to and from remote areas providing an infrastructure for a
commercial bush meat industry. Disease is usually considered the third most serious
threat, and has risen in public awareness due to the highly publicized outbreaks of
Ebola virus in western Africa with resulting high mortalities in chimpanzees and
gorillas (Morell 1995). In protected areas (i.e., conservation areas and national parks)
where deforestation and bush meat practices are a lesser threat, disease is rated as the
premier threat.
In regions where endangered species are highly valued socially, extra efforts
are often needed to conserve the species. When species population levels are low
enough that concern for the genetic integrity of the overall population is valid, each
individual within the population is important. In this scenario, we must augment the
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typical conservation approach of dealing primarily with populations with an
individual-based approach. Each individual contains a significant amount of the
genetic diversity for the entire species, thus, emphasis needs to be placed on the
health and welfare of individuals.
In regions, such as Bwindi Impenetrable Forest National Park and the Virunga
Massif of Central Africa, highly-valued, endangered species, such as the mountain
gorilla (Gorilla beringei), have been historically managed as separate from the
ecosystem. At issue is management of these species at the individual level, while
managing the remainder of the ecosystem at population levels. Today, conserving the
health of terrestrial animal populations is now integrated into the overall management
of ecosystem health (Munson and Karesh 2002).
Currently, the Mountain Gorilla Veterinary Program (MGVP) and
governmental conservation office veterinarians monitor the health of the gorilla
populations by observation, non-invasive biological sampling, and post-mortem
examination. Access to invasive biological samples, such as blood, tissue, etc., is
limited to collection during interventions for life threatening problems and available
archived material. Therefore, a syndromic surveillance system is needed to monitor
and evaluate mountain gorilla health on a daily basis. Rwego (2004) determined that
field observation of clinical signs of mountain gorillas was possible. In the 1997
Uganda Population and Habitat Viability Assessment Workshop, participants
concluded that “presently, there is no effective mechanism of orderly, standardized
collection, management and dissemination of data and materials relevant to mountain
gorilla health.” The recommendation was to “establish an interactive, international
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computerized database” providing epidemiological data as the basis for developing
policies on mountain gorilla health.
The observation health monitoring system described herein is part of a larger
overall health monitoring program developed by the Mountain Gorilla Veterinary
Project called IMPACT. IMPACT is an acronym for Internet-supported Management
Program to Assist Conservation Technologies. This paper describes the theoretical
development of this syndromic surveillance system and initial implementation.

METHODS
The initial hurdle for the development of a syndromic health monitoring
system is to determine what aspect of health should be monitored. Seven parameters
and 26 clinical signs were chosen for observation of gorilla health (Table 2.1). The
system was designed in a hierarchical fashion, such that an observer would first
examine one of the body parameters in its entirety, and if abnormal, describe the
abnormality using the clinical signs. The seven parameters chosen for initial
examination were; body condition, activity, respiration, integumentary, discharge
from the head, discharge from other parts of the body, stool, and other (includes
central nervous system, etc.). Within each parameter, specific signs were developed
to refine possible diagnoses. Rwego (2004) tested the data collection system to
ensure that all parameters and signs were able to be observed and recorded in the
field.
These clinical parameters were chosen because they are part of other
observation systems that have proven effective and they are symptomatic of what are
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thought to be the diseases of major concern for gorillas (Nutter, et al. 2005). Other
observation systems that have been used on great apes include cyber tracker and
Gombe observation. These systems have had varying degrees of success in
implementation. One aspect of similarity amongst these systems is the parameters
that were observed. Because veterinarians can not physically handle the animals nor
ask them about symptoms, they are restricted to viewing the animals for signs of
disease or other problems.
Respiratory diseases have long been thought to be a major source of fatalities
in mountain gorillas (Nutter, et al. 2005). Respiratory diseases, such as pneumonia,
have many symptoms that can be indicative at onset. The parameters and signs for
observation, such as respiration (coughing) and discharge from the head, were
selected with this in mind.
Within each of these parameters, clinical signs were established to refine the
abnormality (Table 2.1). For example, under the parameter of body condition, we
have the sign of abdomen. Finally, within each sign, a level of severity of
abnormality was defined. Within the sign of abdomen, we have the possible choices
of normal, flat and sunken. The choices of flat and sunken indicate 2 levels of
severity for this sign. A flat abdomen is less severe a sign than a sunken abdomen.
Gorillas tend to have a more rotund abdomen under healthy conditions. Table 2.1
provides a listing of all the clinical signs chosen for observation with definitions
(Rwego 2004, MGVP Decision Tree Writing Group In Press).
Although some of the clinical signs are somewhat subjective, the definition
for the levels of severity within each sign helps remove some subjectivity (Table 2.1).
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Additionally, training of field personnel to distinguish normal from abnormal and
levels of severity within abnormality is required. Training materials containing
photographic and/or video footage of live individuals proved useful in training
observers to differentiate normality from abnormality (Figure 2.1). These pictorial
representations of the signs at different levels of severity provide additional
reinforcement to the trainees.
This syndromic surveillance system for the mountain gorillas was designed to
function at the population and individual level. The importance of the individual in
the genetic pool required the system to be able to track any individual over time to
examine changes in health, and generate population level summaries. Consequently,
individuals in the population need to be uniquely identifiable. Nearly 2/3 of the
estimated 740 mountain gorillas are known and named via unique nose prints. Most
of these gorillas are visually located on a daily basis. This allows the system to be
based around a population of known individuals. If the system needed to only be
used at the population level, it could easily work for any population where individuals
are not known; calculating the occurrence of clinical signs at the group or population
level from all individuals documented.
A demographic table was developed to maintain information such as gender,
date-of-birth, parental lineage, and date-of-death for all the gorillas. This information
strengthened the capability of the system by allowing researchers to examine the
effects of gender, age, and lineage on risk of clinical sign or death.
The IMPACT system was designed using a relational database system to
maintain health information. The freeware database of MySQL was used for data
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storage and the php programming language was used for the development of the
interface to the database. Data are maintained in a manner to provide an assessment
or case history of a single individual within the population or the group or population
as a whole. Researchers may need to evaluate the progression of a disease through
the clinical signs that develop over time. This individual assessment provides insight
into how others within the group may respond to the same illness.
Additionally, the group or population needs to be monitored at the same time
to evaluate the rate of spread of the disease within the population. Basic
epidemiological curves or incident rates are often used for this purpose (Thrushfield
1995). If the population is in a potential outbreak situation, plans need to be
developed if treatment is deemed necessary and is a viable option (Chapter 3). Thus,
the system accumulates data on groups and populations to provide baseline
information as to what is expected in terms of clinical signs. Similarly, it may be
important to evaluate the spread of disease among species. Spatial location
information allows the analysis of disease spread across groups, sub-populations, or
species. Thus, global positioning system (GPS) locations are taken at all sampling
locations.
The gorillas occur in multiple locations within their range and are observed by
more than one individual, therefore, provisions need to be developed for a multi-user
system. With this, all observers need to be able to maintain a current database of
individual gorillas (with births and deaths) and observation records of other
observers. Currently there are gorilla groups that will migrate across country borders
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in the Virunga Massif, thus, observers in each of the countries need to maintain
current information on the group in case they show up at their location.
Because all epidemiological profiles require knowledge of the total number of
individuals within the group or population, it is imperative that each observer know
how many individuals exist. If an animal dies and this information is not updated in
the database used by other observers, the estimate of overall rate of infection (or
observability of a sign) will be biased low. In very small populations, this situation
can have significant impact on estimates of epidemiological parameters.
An additional problem that can affect the epidemiological profile of the
mountain gorillas when examined at a group level is migration of individuals between
groups. To get quality estimates of rates of signs, all individuals seen on a given
observation need to be recorded. Thus, the system is able to either add unknown wild
animals to an observation, or add known individuals from another group to an
observation.

RESULTS
The development of the IMPACT program has proven most challenging. An
electronic version of the data collection form was developed for handheld personal
data assistants (PDA) (Figure 2.2). The PDA program provided the observer with a
complete list of known gorillas and gorilla groups in the Virunga Massif and Bwindi
Impenetrable Forest National Park (Figure 2.3). Data entry for most items was a
simple tap and select function except, where additional notes were required (Figure
2.4).
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The main component of the IMPACT system was a web-based data
management system (Figure 2.5). The system was password secured to prevent
unauthorized access to data on these endangered animals. All components
programmed into the PDA also were available on the web-based system (Figure 2.6).
This allowed for entry of information if observers used a paper form for data
collection. Entry from the PDA data collection program was through an import
function. Upon import, the data are analyzed and summarized (See Table 3.2,
Chapter 3). The IMPACT program also produces summaries of information in a
visual format to aid protected area managers with management decisions (Figure 2.7).
As of July 1, 2006, there are over 1000 observation records in the IMPACT system.
The number of observations will expand exponentially as the system evolves from the
testing phase to the implementation phase.
Researchers in different areas of the Virunga Massif tend to collect GPS data
in different coordinate systems. Some researchers collect data in the Universal
Transverse Mercator, whereas others collect data in Latitude and Longitude. This
presents issues upon data entry and analysis. These data must be converted to be
spatially comparable. The system was designed such that individuals inputting data
are required to select either UTM or LAT/LONG as a coordinate system. This allows
the system to automatically convert the coordinates to a standard system. Latitude
and longitude with the underlying datum of the World Geodetic System of 1984
(WGS84) is the standard for data storage.
Spatial referencing information provides greater flexibility of the data. Spatial
location information on daily observations can be used to calculate home ranges
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(Figure 2.8) or simply examine the spatial distribution of a specific disease (Figure
2.9).
One aspect of the development of the IMPACT system that was initially
overlooked was the size and complexity of the web pages. The IMPACT system
could have been developed much more easily using the internet capabilities of
developed countries. Creating the system to function at the level of a field station in
central Africa was much more challenging. All web pages were developed to be less
than 100 KB in size and most were less than 50 KB in size. Additionally, most pages
could not be dynamic in nature. A dynamic page requires reloading at every change;
this was not feasible at a transfer rate of 500-900 bytes/sec. as experienced in Africa.
Any system based on observation of wild animals requires testing. Testing
needs to be conducted to ensure that the parameters and clinical signs can actually be
observed. Rwego (2004) demonstrated that the parameters and signs established in
the observation system could be observed. Additionally, he documented that
observability of signs differed across gender and age classes (Figure 2.10). The
reliability and validity of any survey instrument also needs to be tested. If an
instrument cannot produce consistent results across multiple observers, or if the
results are not indicative of actual events, then it is not a useful tool. The observation
system is currently being evaluated under controlled experimentation for validity and
reliability.
DISCUSSION
The ecology of wildlife diseases has changed rapidly over the last decades.
Alteration and fragmentation of the landscape due to human expansion and resultant
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shifts in wildlife populations has increased interspecies contact; translocating
pathogens to new locations and hosts (Wilson 2000).
Munson and Karesh (2002) provided suggestions for integrating animal health
into conservation management strategies. They suggested that a new realm of
conservation is developing. This realm of conservation is multi-disciplinary in that it
links wildlife ecology with veterinary medicine. Many people are calling the field
“conservation medicine.” Munson and Karesh (2002) suggested that given the right
sentinel species, a means of monitoring the ecosystem would be feasible. Thus, a
health monitoring system that is capable of dealing with any species with either
known or unknown individuals can be applied on a worldwide scale. The IMPACT
system is designed with this aspect in mind. Although it has been developed around
the mountain gorillas of central Africa, it can be applied to any species in any location
around the globe.
Because of the intervention policies in place around the mountain gorillas, it is
not possible to physically handle or treat animals for routine monitoring. Therefore,
MGVP is restricted to the use of this syndromic surveillance system. As more and
more data are collected on the presence of clinical signs, we can start to compare the
progression of signs in an individual as it relates to specific diseases and how these
signs spread throughout the group as the disease spreads. Currently, signs or
combinations of signs have not been tested to be quality predictors of specific
diseases. This testing process will need to be conducted as more and more reliable
data on the gorillas is amassed. Signs may be gender and age class specific with
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some diseases. The system described herein will be able to handle this issue using the
demographic information associated with each observation.
As information on the prevalence of clinical signs comes available, Protected
Area Managers and MGVP veterinarians will have greater recourse to suggest
treatment of individuals to prevent spread of disease and possible death. A clinical
decision tree to determine when the number and type of signs is considered an
outbreak has already been defined (Chapter 3, MGVP Decision Tree Writing Group
In Press). As more information amasses in the IMPACT system, a change in the
intervention policies of Uganda, Rwanda and Democratic Republic of Congo will
likely occur. Countries will likely be more open to intervention if it can be shown
that individuals have a high probability of mortality with a specific combination of
clinical signs or if spread of disease is likely.
The IMPACT system is still evolving and developing. As it does, other
research groups will see the benefit of monitoring wildlife populations for health.
The Lincoln Park Zoo, in conjunction with the Jane Goodall Institute, has already
adopted the use of the program for chimpanzees in their main study area in Gombe,
Tanzania. Additionally, the Wildlife Conservation Society (WCS) field veterinary
program is teaming up with MGVP to expand the program to include GIS analysis of
observation and test results of biological samples. WCS has plans to use the program
worldwide for threatened and non-threatened species alike. Both organizations see
the benefit of using a system like IMPACT to maintain health related information and
make management decisions about threatened and endangered species around the
globe.
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Table 2.1. The data dictionary of the clinical parameters and signs with severity
ratings for the clinical decision tree of the Mountain Gorilla Veterinary Project.
Severity Rating
Mildly or
Moderately
Abnormal
Thin: a) estimated
<10% loss of weight
b) able to see the
ribs
c) notable muscle
atrophy

Parameter

Clinical Sign

None or
Normal

Body Condition: the
physical state of a
gorilla as
distinguished from
attitude and
behavior

Weight: body
composition in
terms of muscle
mass and body fat

Unable to see the
ribs and muscles
appear normal

Abdomen: part of
the body that lies
between the thorax
and the pelvis

Abdomen extends
beyond the ribs
(convex in
appearance)

Flat (Abdomen and
ribcage form
continuous line)

Sunken: Abdomen
sunken and concave

General Attitude:
The manner of
acting

Age and sex
specific appropriate
behaviors

Behavior not like
rest of the members
at a particular time
of day or in a
particular context.
e.g. lethargy, listless

Performing
severely
inappropriate
behaviors in the
context of the
environment. e.g.
still in the nest after
9 am or at one spot
> 1 hour with no
body manipulation

Manipulation: Any
manual movement
with limbs. e.g.
eating, grooming
etc.

Normal movement
of the limbs of the
body

Unable to perform
normal movements
of any part(s) of one
or more limbs

Unable to perform
normal movements
of any part(s) of
one or more limbs,
high degree of
dysfunction present

Movement: The act
of passing the whole
body from place to
place

Normal movement
of the whole body

Lameness:
Abnormal
movement of one or
more limbs leading
to the individual
limping

Severe Lameness:
unable to keep up
with the group,
abnormal
movement of 1 or
more limbs

Breathing rate:
Frequency of
breathing, recorded
as no. of
breathes/minute

When the observer
visualizes the
nostrils and the
chest and the animal
appears comfortable
and you barely
visualize the
movement of the
chest and there are
no audible sounds

Slow: Breathing
observed as <15
breathes/minute and
audible sounds
may/may not be
heard

Fast: When
breathing is >25
/minute with/
without audible
sounds in a resting
state

Activity: Quality of
being active

Respiratory: relating
to respiration which
is the taking in of
oxygen and
expiration of
oxidation products
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Highly Abnormal

Very thin: a) >10%
loss of body weight
b) ribs obviously
pronounced
c) atrophy of fat,
muscles, sunken
eyes

Table 2.1. (cont.)

Integumentary:
Includes the
epidermis, dermis
and all of their
derivatives i.e. hair,
nails, sebaceous
glands, and
mammary glands

Breathing difficulty:
a problem in
exhalation &
inhalation

No breathing
difficulty shown

Labored: Visible
respiratory effort by
an individual
without respiratory
noise

Extremely Labored:
Visible respiratory
effort by an
individual with
audible respiratory
noise

Coughing quality:
Coughing is sudden
explosive forcing of
air through the
glottis & larynx

No coughing

Dry: Harsh, grating,
short sound with no
mucus production

Productive: Moist
sounding cough
associated with
exudates

Coughing pattern:
The sequence of
coughing

Doesn't interrupt the
activities of an
individual

Continuous:
Coughing >1 time
in 5 minutes And
interrupts the
animal’s activities

Sneezing: Expelling
air from the nose
and mouth by
involuntary
spasmodic
contraction of
muscles of
respiration

One or fewer
episodes of
sneezing per
observation

Periodic:
Intermittent
interruption of the
individuals
activities due to
coughing
Periodic: Episodes
of sneezing that are
isolated events with
periods of >15
minutes between
them

Skin and Hair: The
tough membranous
tissue that forms the
external covering of
the individual and
may have hair
(includes visible
mucous
membranes)

Skin and hair as
expected for the
species

Scaly: Flaky,
whitish looking
pieces of epidermis
sloughing off the
body
Loss of hair:
reduced density of
hair
Other skin/hair
health problems:
rashes, redness,
ulcers , erosions
pustules, nodules
maculae, scars, and
thickenings
Blisters:
collection(s) of fluid
under the epidermis
or within the
epidermis

Extensive or
extreme variations
of Scaly, Blisters,
or Other skin/hair
problems
with/without
pruritis

Wounds: An injury
to any part of the
tissues of the body
caused by trauma or
disease

Intact
Integumentary
System

Cut: Superficial and
limited to the skin
surface
Gash: More than
just skin surface
affected up to the
muscle layer

Severe Gash: More
than skin affected,
muscle and/or
function of a
system impaired
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Continuous: >1
episode of sneezing
within <5 minutes

Table 2.1. (cont.)
Scratching: To rub
to alleviate itching
utilizing nails or
other objects

No scratching or <1
scratch per 30
minutes

Periodic: Scratches
now and then >1
time every 30
minutes

Continuous:
Scratching
occurring >1 time
every 5 minutes or
continuously for >1
minute

Swelling Number:
The number of
swellings on the
individual’s body

None

One: one swelling
on the observed
portion of the body

Many: More than
one swelling on the
observed portion of
the body

Small: Little in size
or extent (< 2.5 cm
in diameter)

Large: (> 2.5 cm in
diameter)

Swelling Size: the
size of any
abnormal
enlargement on any
part of the body

Gastrointestinal:
(feces)

Discharge:
substance that is
emitted or
evacuated as a
secretion

None

Clear, Dried

Bloody, Other
color: white,
yellow, green,
cloudy

Defecation: the
discharge of
excrement from the
rectum

Controlled
elimination

Straining: excessive
effort in excreting
feces from the
rectum

Same as moderate
but continuous

Stool Color: color
of the stool

Brown

Other:
White/yellow, etc

Black- dark colored
stool possibly
indicating blood
from the upper GI
tract
Bloody Red:
Reddish tinge or
flecks of red in the
feces indicating
blood from the
lower GI tract

Stool consistency:
the degree of texture
or viscosity of the
feces

Feces with the
expected
consistency and
discrete lobes

Dry: harder than
normal (lacking
moisture or water)
Other: a mixture of
soft feces and hard
ones or contains
particulates
Soft: No longer
retains its normal
shape but has a
"pudding"
consistency

Watery: stools no
longer retains any
shape or
consistency
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Table 2.1. (cont.)
Other Signs: Signs
other than what is
described above.
e.g. CNS,
Reproductive

EXAMPLES

Normal movement
and activity

Ataxia and
stumbling,
Hyperactivity and
response

Coma, Paralysis,
Seizures

Prolapsed rectum

Not observed

Observed +/frequently but self
corrects

Permanent
prolapsed, swollen,
maggots

Vomiting

Not observed

Observed once

Frequent vomiting

Dystocia

Not observed

Slow but
progression made

No progression and
female exhausted
and showing signs
of lethargy

Central Nervous
System
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Stool
• Stool Consistency
– Dried
– Normal
– Soft
– Watery

Figure 2.1. An example of training materials used to define and demonstrate the
abnormal and normal clinical parameter of stool consistency using photographs of
field examples.
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Figure 2.2. Screen capture of the electronic version of the IMPACT data collection
program developed for handheld personal data assistants (PDA).

46

Figure 2.3. The IMPACT PDA program provides the observer with a complete list of
known gorillas and gorilla groups in the Virunga Massif and Bwindi Impenetrable
Forest National Park.
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a.

b.

Figure 2.4. Data entry for most items in the IMPACT data collection program is a
simple tap and select function except where additional notes are required.
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Figure 2.5. Screen capture of the main component of the IMPACT system which is a
web-based data management component accessible from anywhere in the world.
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Figure 2.6. Screen capture of the IMPACT web program showing that all
components programmed into the PDA are also available on the web-based system.
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Figure 2.7. A monthly summary of normal and abnormal signs of the Nkuringo
gorilla group produced by the IMPACT program to aid Protected Area Managers with
management decisions.
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Figure 2.8. Home range calculation of the Nkuringo gorilla group based on
observations conducted for health analysis from March 2002 to March 2003 (from
Rwego 2004).
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Figure 2.9. Visual display of cattle samples collected in Rwanda summer 2002 that
are positive and negative for Cryptosporidium spp.
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54

CHAPTER III
CLINICAL RESPONSE DECISION TREE FOR THE MOUNTAIN GORILLA
AS A MODEL FOR GREAT APES

ABSTRACT
Disease is one of the main threats to the remaining great ape populations of
the world. The decision to intervene in the health of individual great apes for
population sustainability is controversial. Humans’ increasing negative influence on
great ape health has mandated the need to reevaluate the policies of current
management practices. The Mountain Gorilla Veterinary Project has been making
health intervention decisions since 1986. The decision to intervene has often been
subjective due to poorly defined criteria often influenced by emotion. This paper
provides a consistent framework for evidence-based health intervention decision
making. The decision tree is a 5-tier process consisting of routine sentinel health
observation, intensive follow-up veterinary health observation, outbreak assessment,
risk assessment, and risk management. Although the paper is based around the
mountain gorillas, it serves as a basis for evidence-based decision making in other
species.
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INTRODUCTION
Great apes, the orangutans (Pongo pygmaeus) of Borneo and Sumatra, and the
chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas (Gorilla sp.) of
Africa are facing uncertain futures with their long-term sustainability in question
(Butynski 2001). The most prominent threat to their survival is habitat
destruction/fragmentation from logging and agricultural activities. The second most
serious threat relates to the development of roads associated with logging, allowing
access and transport to and from remote areas providing an infrastructure for a
commercial bush meat industry. Disease is usually considered the third most serious
threat, and has risen in public awareness due to the highly publicized outbreaks of
Ebola virus in western Africa with resulting high mortalities in chimpanzees and
gorillas (Morrell 1995). In protected areas (i.e., conservation areas and national
parks) where deforestation and bush meat practices are a lesser threat, disease is rated
as the premiere threat.
In 1997, the Population Habitat Viability Assessment held by the
Conservation Breeding Specialist Group (CBSG) in Uganda, placed disease
introduction as a major risk to the sustainability of the two populations of mountain
gorillas (Gorilla beringei) in the protected areas of the Virunga Massif and Bwindi
Impenetrable Forest (Werikhe et al 1997). These parks have sharp boundaries
between the forest and the human communities, with few existing buffer zones. The
human communities around the mountain gorilla parks have a density of between
423-538 people/km2 (2002 Rwanda Census, Office National de la Population
(ONAPO), Revue du Rwanda sur population et development, No 38, June 2003) and a
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population growth rate of approximately 3.7%/year (Butynski 2001). The mountain
gorilla populations have the greatest percentage of human-habituated individuals of
any ape species and are subjected to intense research and ecotourism programs.
These factors, compounded by agricultural practices at the boundaries of the park,
promote contact between gorillas, humans, and domestic animals, increasing the
potential for the introduction and transmission of infectious diseases. The health care
within the human and domestic animal populations around the parks is less than
optimal and poor sanitation exists. Research has shown through genetic sequencing
that the same enteric organisms (Giardia spp., Microsporidium spp. and
Cryptosporidium spp.) are circulating amongst humans, cattle, and gorillas in and
around the park (Nizeyi et. al. 1999, 2000, 2001). The prevalence of antibiotic
resistance to Enterococcus and E. coli in mountain gorillas has been found to be
greater than expected for wild populations of animals and has a similar pattern to
human and cattle antibiotic resistance in the Bwindi area (Byarugaba, D. Makrere
University, unpublished data). Gorillas share greater than 98% genetic similarity
with humans (Hacia 2001) and are susceptible to many of the diseases of humans,
including the zoonotic diseases associated with livestock.
Opportunistic blood samples have shown that the gorillas lack antibodies and
are probably naïve to many diseases endemic to other species the region (i.e.,
measles); these, if introduced into the gorillas, may cause high morbidity and
mortality, thus making this a high risk population for a serious epidemic (Hastings
1991, Nutter et al. 2005). The Mountain Gorilla Veterinary Project (MGVP),
supported by the Morris Animal Foundation, was formed in 1986 at the request of
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Dian Fossey to provide emergency medicine and pathology services to the mountain
gorilla population of Rwanda (Cranfield et. al. 2002). Due to low numbers of gorillas
in these populations and genetic studies showing that each animal's genetic input into
the population's genome is important (Garner and Ryder 1996), the mountain gorillas
are managed on an individual as well as a population basis with respect to veterinary
care (Cranfield et. al. 2002).
Veterinarians, trackers, guides, researchers and other personnel from MGVP,
the Ugandan Wildlife Authority, Office Rwandais du Tourisme et des Parcs
Nationaux, the Institut Congolais pour la Conservation de la Nature, Dian Fossey
Gorilla Fund International and the Institute for Tropical Forest Conservation monitor
the health of the gorilla populations. Although health monitoring is done by 1)
observation, 2) non-invasive biological sampling, and 3) post mortem examinations,
the data has not been collected in a uniform fashion. The collection of important
baseline medical data from invasive sampling of live animals had been conducted on
an infrequent, non-standardized opportunistic basis. To better understand the basic
epidemiology of diseases within the ecosystem and monitor gorilla health, a
standardized method of data collection and analysis was developed and implemented.
Any veterinary interaction (darting, treating, anesthetizing, etc) of a gorilla(s)
is considered an intervention. Interventions (with or without immobilization) are
regulated by the protected area authorities and veterinarians and have occurred only
in the presence of human-induced or life-threatening health problems. This
intervention policy has been ambiguous, often subjective, and emotional.

58

From a process designed to develop a contingency plan, a method to
standardize data collection was created that included concerns of all stakeholders. As
a byproduct, this lead to the design of the clinical decision tree to standardize the
intervention response to health-related issues. This decision tree is helping to ensure
standardized data collection, so that meaningful comparisons can be made to better
assess risk and risk management options. In this chapter, the logic and structure of the
clinical decision tree developed by MGVP is outlined with examples of how the
system would function in relation to outbreak and non-outbreak situations.

DEVELOPMENT
The Mountain Gorilla Veterinary Project’s clinical response decision tree was
created for 2 purposes. The first purpose was to standardize protocols for risk
assessment to aid veterinarians and managers in making objective evidence-based
intervention decisions that are easily communicated and provide consistency in
veterinary care between clinicians in the face of three different countries’
management systems. The second was to categorize risk and therefore, act as a trigger
to commence the actions outlined in a previously developed contingency plan aimed
at reducing the likelihood that a disease, once introduced, will cause a major outbreak
or epidemic in the mountain gorilla population.
The development of the decision tree process spanned 2 regional meetings of
gorilla conservation organizations, which included non-governmental organizations
(NGO’s) and the protected area managers of the Democratic Republic of Congo,
Uganda, and Rwanda. The first iteration was created by several field and captive
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primate veterinarians and veterinary and human epidemiologists. After input and
discussion by all stakeholders, it was edited by the Contingency Plan Team of
MGVP. This chapter provides a summary of the final product.
To be useful and practical, the decision tree remains a dynamic document and
is designed to be applicable for use in other, similar, wildlife situations. Clinical
decisions are reactionary in nature. However, clinical signs considered normal in one
animal can portend an outbreak in another situation. A good decision process must
help distinguish between these 2 situations and trigger a response only when
necessary.
In many cases, clinical interventions are based on the presence of clinical
signs alone. Because these are often non-specific, and therefore not associated with a
definitive diagnosis, the severity of the observed signs may be the best indicator of
risk for timely response. To address this issue, a severity index of clinical signs was
created; terminology was standardized through the use of a data dictionary (Table
3.1).
A quality decision support tool utilizes analytical methods, such as decision
analysis, optimization algorithms, and program scheduling routines for developing
models to help decision makers formulate alternatives (Adelman 1992). For the
decision tool to function effectively, the expertise of the collective users (in this case
wildlife veterinarians) must be captured in such a manner to fit into a decision
algorithm. This decision tree was developed in such a manner as to flow through a
decision process similar to how a veterinarian would analyze the situation.
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THE DECISION TREE PROCESS
The decision tree process consists of 5 hierarchical levels that follow each
other in succession (Figure 3.1);
Level 1: Collection and review or routine sentinel health monitoring data by
trackers, guides, and/or behavioral researchers using a basic standardized health
observation form, either paper based or a specially programmed personal data
assistant (PDA).
Level 2: Intense follow-up observations by trained health personnel using a more
complex form focused on abnormalities from the basic observation data with a
more detailed level of review.
Level 3: Outbreak assessment that places the scenario into either an outbreak or
non-outbreak category by the prevalence of clinical signs or a definite diagnosis.
Level 4: Assessment and categorization of the outbreak into low, medium, or
high risk at individual or population levels.
Level 5: Risk management through implementation of the contingency plan.

Level 1: Routine health monitoring and review
Routine sentinel observational monitoring is the foundation of the health
program for the mountain gorilla. Individual animals are observed for abnormalities
that may indicate a health problem. Routine health observation data is gathered either
by the trackers and guides or researchers on either a paper form or a PDA. Data is
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downloaded into an internet-based data system, (produced by MGVP Database Team)
called IMPACT™ (Internet-supported Management Program to Assist Conservation
Technology). A strict data dictionary (Table 3.1) in conjunction with thorough
training ensures the consistency and accuracy of the data.
Using the PDA, the observer identifies and enters the name of the group they
are observing and the PDA automatically lists names of individual gorillas in the
chosen group. If the observer is using the paper form he/she picks the pre-made form
that contains the names of the gorillas in the group being observed. The observer
then records whether an individual animal was or was not observed (Figure 3.2a). If
an animal is marked observed, the program asks which of the following parameters
were observed A) body condition, B) activity, C) respiratory system, D) skin/hair, E)
discharge from head orifices, F) discharge from other areas of the body, G) stool and
H) other parameters (Table 3.1). Each parameter is then recorded as normal or
abnormal with the ability to enter a text description for each abnormality noted
(Figure 3.2b).
Paper collected data is entered into an internet interface, whereas PDA data can
be directly uploaded into IMPACT. Once data is uploaded, reports are automatically
generated by IMPACT as in Figure 3.3. If no abnormalities were reported on the
observation, no further action would be indicated by the decision tree. The observation
data is used to compile normal prevalence rates of parameters observed (see Figure 3.1,
Level 1). Thus, IMPACT is a valuable tool for epidemiological evaluation of an
outbreak in a uniform and statistically valid fashion. In cases where Level 1 routine
observations indicate abnormal systems (Figure 3.4), the tool will direct the
62

veterinarian or trained health personnel to complete Level 2, intensive follow-up
observation, for complex data collection and review (see Figure 3.1, Level 2).

Level 2: Intensive follow-up observation, with a more complex data collection and
review
The second level of data collected for input into the decision tree requires
trained field health personnel to conduct a second observation of the group to confirm
accuracy of basic data. This evaluation uses a more detailed and complex paper form
or PDA observation module in the IMPACT program. This program is very similar
in design, function and use to the basic level program, but when a parameter with an
abnormality is entered (Figure 3.5a), a screen appears with a list of strictly defined
clinical signs to describe the abnormality in greater detail (Table 3.1, Figure 3.5b). If,
as in the example of Figure 3.4, a routine basic observation report indicates
abnormalities, and a subsequent intensive follow-up observation shows that the
abnormalities are resolved (i.e., the animal stopped coughing and the wound is
healing), no further action would be taken and data is stored in the database of
epidemiological information. If the intensive follow-up observation shows abnormal
clinical signs, as in Figure 3.6, then the decision has to be made as to whether the
abnormality should be considered a non-outbreak or outbreak situation (see Figure
3.1, Level 3).

63

Level 3: Outbreak assessment
An outbreak is defined as the occurrence of a disease or other health related
event in excess of what would be expected for the specific region and period of time.
Although an outbreak may be defined by a single case, the term often implies that
several individuals are affected. Important considerations in the investigation of an
outbreak of infectious disease includes determining that an outbreak is, in fact,
occurring and defining the extent of the population at risk. Given that data gaps exist
in knowledge of the baseline prevalence of clinical signs and diseases in the mountain
gorilla, outbreak assessment may initially prove to be the most challenging task. In
the past, the identification of an outbreak was based on the collective experience and
subjective judgment of the park manager and veterinarians. Presently, outbreak
definitions are defined by using past clinical observations and the new data being
amassed by IMPACT, with the ability of the veterinarians and park managers to
confirm or override the program at any point. One benefit of this system is that
IMPACT records and updates the prevalence rates of clinical parameters and signs
spatially and temporally as it monitors for health. Thus, observations on healthy and
sick/injured animals allow continual refinement of estimates of “normal” prevalence
rates. This has been one of the faults of historical non-uniform health data collection
where frequently only data from unhealthy animals were recorded.
In Figure 3.4, if abnormal clinical signs are equal to or less than expected
based on normal prevalence rates (i.e., the coughing resolved, but the cut turned out
to be a snare) it is considered a non-outbreak situation (see Figure 3.1, Level 4) and
the data are stored. Non-outbreak assessments usually deal with individual welfare
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issues. If the prevalence of abnormal clinical signs is greater than expected, as we see
in Figure 3.6, then the scenario would be assessed as an outbreak (see Figure 3.1,
Level 4). Outbreak risk assessment would more likely involve population welfare.

Level 4: Risk assessment and categorization into low, medium or high risk
Risk assessment is the process of estimating the implications of a
disease/hazard introduction and results in a final estimate or characterization of the
risk. Risk assessment is a logical process by which risks are evaluated based on
available scientific information. This standardized format for risk assessment
supports veterinarians to make evidence-based decisions in the field. It also provides
organization to vital communication efforts between field personnel, the park
authority, veterinarians and other NGO-stakeholders. For the process to work and
ensure transparency, both the assumptions made and the factors contributing to
certainty in estimates of risk must be fully elucidated and documented.
The vast majority of the time in the field, risk assessment is based on
observational/clinical signs due to the limited availability of quantitative information.
Therefore, the assessment is primarily qualitative in nature. Qualitative risk
assessment, although not as desirable as quantitative assessment, has been recognized
as a valid tool by the World Trade Organization, the Food and Agricultural
Organization of the United Nations, and the Organization of International Epizootics.
This decision tree must function in the stochastic world of veterinary medicine in a
field situation. It therefore, must deviate from decision mechanisms used in human
medicine. These deviations include dependency on observed clinical signs rather
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than verbal communication for patient assessment, the risk and difficulties in
performing routine physical exams on gorillas, and the necessity, in most cases, for
anesthesia of the animal for sample collection and treatment. Available human
diagnostic tests may or may not be validated for gorillas, leading to their questionable
diagnostic value. The risk assessment decision tree process is initiated by qualitative
data, but quantitative data should be collected for confirmation or to reduce
uncertainty in the characterization of risk. Over time IMPACT will acquire the
quantitative data needed to help make the decisions more objective.
Level 4A: Risk assessment for an outbreak scenario: Risk assessment for an
outbreak usually involves group or even population level decisions. This paper
presents two methods by which outbreak risk can be assessed. The first method,
disease diagnosis, is derived from clinical signs or diagnostic test results, (i.e.,
examples in Table 3.2). The categories of low, medium and high risk are derived
from data on morbidity and mortality rates from human medicine, experience with
non-human primates in captivity, and limited disease experience from wild ape
populations. Table 3.2 updates occur as new information becomes available. The
second method, in cases where a definitive diagnosis cannot be made, incorporates a
combination of clinical signs, postmortem examination results and estimated
transmission and mortality rates (Table 3.3). Data are analyzed by the IMPACT
system and placed into risk categories and implementation strategies that are then
confirmed by veterinarians. Risk categories were compiled from past experiences by
a team of experienced field and captive primate veterinarians, as well as veterinary
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and human epidemiologists. Table 3.3 is dynamic and will constantly be updated as
IMPACT incorporates its own data into the decision tree.
To make risk categorization consistent and functional, parameters and clinical
signs were defined and ranked by severity (Table 3.1). The rate of transmission is
defined as low (0-1 new cases in >3 days), medium (1 new case every 2-3 days), and
high (1 or more new cases per day). Mortality rates are defined the same as rates for
transmission. Prior to multiple observations when transmission and mortality rates
can be calculated, the field veterinarian must rely on past experience to estimate these
rates.
Level 4B: Risk assessment for a non-outbreak scenario: The non-outbreak risk
assessment usually involves decisions on an individual level rather than population
level. Clinical signs are characterized by the likelihood that they are infectious or
non-infectious, as well as, the likely route of introduction. If signs are human
induced, life threatening and treatment is beneficial and practical, immediate
intervention is warranted. If the situation is non-human induced, whether infectious
or non infectious, then the following decision making criteria are used:
A)

Low Risk: Not likely life-threatening and will probably resolve without
treatment,

B)

Medium Risk: Potential to be life threatening and may need treatment,

C)

High Risk: Likely life-threatening and needs treatment.
Because “natural” injuries and mildly abnormal clinical signs occur as part of

the gorilla’s natural history, this non-outbreak intervention decision is still somewhat
subjective and often relies on demographic information for decision making. Once a
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risk assessment and categorization is complete, risk management protocols should be
implemented (Figure 3.1, Level 5).

Level 5: Risk management
The goal of risk management is to reduce implications or recurrence of an
introduced hazard. Risk management plans must be tailored to the situation but basic
recommendations exist within the decision tree; risk management or implementation
plans were developed for each risk category in both outbreak and non-outbreak
situations (Figure 3.1, Level 5).
Risk management actions in non-outbreak situations
Low Risk Category Actions:
1) Continued observation,
2) Collection of non-invasive samples if deemed necessary,
3) Reporting the problem to the Protected Area Authorities (PAA), the Host
country wildlife Veterinary Authorities (HVA) and the MGVP Project
Director (PD).
Medium Risk Category Actions:
1) Review demographic information
2) Consider immobilization and collection of invasive samples,
4) Provide treatment or any beneficial preventive action,
5) Communicate this to the PAA, HVA and PD,
6) Continue to monitor and report as for low risk.
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High Risk Category Actions:
1) Review demographic information,
2) Perform an immobilization for sample collection and treatment,
3) Make sure that international export permits are ready to ship samples if
necessary,
4) Contact outside help if deemed desirable,
5) Formulate a written action plan,
6) Communicate this to the PAA, HVA and PD.
Gorillas occasionally get their hands or feet accidentally caught in snares set
to catch other animals. They are generally strong enough to break these snares free
from their grounding but are usually left with ropes or wires attached to their limbs.
This is one example of a non-outbreak situation because it usually only involves one
animal and there is no potential to transmit the problem to other gorillas. The fact
that snares are human induced, and often life-threatening, calls for immediate
intervention.
Risk management actions in outbreak situations
Low Risk Category Actions:
1) Continue to observe and assess for progression to moderate or high risk,
2) Perform collection of non-invasive samples,
3) Produce reports on MGVP response and observation to the PAA, HVA,
and PD.
Medium Risk Category Actions:
1) Intensify observations to watch for advancement to high risk,
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2) Perform immobilizations if deemed necessary for diagnostic invasive
sample collection,
3) Notify the PAA, HVA, PD, other appropriate stakeholders and public
health officials,
4) Prepare a formal report and written action plan on problem, and MGVP
activities.
High Risk Category Action:
1) Perform intervention(s) for diagnostics and treatment,
2) Assess new information and redefine plan if necessary,
3) Obtain additional help from regional or international resources/experts,
4) Put potentially necessary health resources on standby,
5) Obtain international export permits and distribute written protocols for
immobilizations, treatments and drug dosages, vaccinations and
diagnostics to the invited health providers,
6) Communicate to all appropriate people (PAA, HVA, PD, stakeholders and
public health officials),
7) In the face of an expansive and extreme outbreak the most extensive part
of the contingency plan is implemented. Where international veterinary
assistance is necessary, other expertise such as epidemiologists, GIS
experts and consultation with the Center for Disease Control and
Prevention and the World Health Organization should be used.
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APPLICATION
To illustrate the flow process of the decision tree, 4 scenarios have been
established (Figures 3.3, 3.4, and 3.6). In the first scenario (Figure 3.3), the level 1
observation of the trackers and guides finds no abnormalities in any of the gorillas
observed on that day. The decision tree does not progress to the second level, but
does integrate the information into the IMPACT database to enhance the decision
power for detecting outbreaks. In the second scenario, the level 1 observation does
detect abnormalities in at least one gorilla (Figure 3.4). Specifically, Kabatwa was
detected with a cut on the wrist and Turiho was heard coughing, both abnormal signs
by definition in the data dictionary (Table 3.1). The decision tree will automatically
flow from level 1 to level 2, requiring a more intensive follow-up observation by a
veterinarian. The data collected by the veterinarian will then determine the next flow
path for the decision tree. If the cut on the wrist is healing fine and the cough is no
longer detected (i.e., both signs verified and determined negative), the data from both
the level 1 or tracker and guide the day before and the level 2 or veterinarian followup will be incorporated into the database. Conversely, if the level 2 follow-up
determines that either the cut on Kabatwa’s wrist or the cough is still abnormal, then
the decision tree flows to level 3; the outbreak assessment.
Ultimately, the system will determine outbreak vs. non-outbreak status using
the data amassed with the IMPACT database. The system will determine if levels of
signs are greater than expected for that group, age class, and season. Until enough
data are available for this automated check, the outbreak assessment must be
conducted based on past clinical experience of the field veterinarians and the
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protected area managers. In the example in Figure 3.6, a second gorilla (Guhonda)
has been detected with the same clinical signs as Kabatwa the day before. The
veterinarians and protected area managers would determine this to be an outbreak
situation. Thus, the decision tree would flow to level 4, risk assessment in the
outbreak pathway.
The risk assessment of the severity of the outbreak is determined using the
factors in Table 3.3. The example in Figure 3.6 shows a scenario with greater than
normal prevalence of abnormal clinical signs, or an outbreak situation of medium risk
(Table 3.3) where the rate of transmission is high (≥1 new case/day) but the mortality
rate is low (no mortality observed).
Once the risk is categorized as a medium risk, the decision tree flows to level
5, the risk management of an outbreak situation with medium risk. The decision tree,
under this situation, recommends the continued intensive monitoring of the group to
determine changes in the number of cases or severity of clinical signs, either of which
could push the situation into a high risk category. Diagnostic sampling of the sick
individuals should be considered. Immobilization of Kabatwa and Guhonda should
be considered a possibility if invasive samples are required (i.e., blood, etc.), or
simply fecal and urine samples may need to be collected. If samples are collected,
export permits may be required to get samples to the appropriate laboratories in the
U.S. or Europe. Treatment for the 2 animals with an antibiotic also would be an
alternative. If the situation persists in a medium risk level, regional help from other
parties may be required. Either way, an action plan should be drafted in case there is
need to immobilize or treat any of the gorillas. Finally, the MGVP project director,
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protected area manager, any local stakeholder groups and the public health officials
should be informed of the outbreak situation.
If on the other hand, the cough of Kabatwa resolves before the level 2 followup but the cut on Turiho’s wrist is determined to be a snare, then the decision tree will
assess the situation at level 3 as a non-outbreak and proceed to level 4 along the nonoutbreak path. Because a snare is a human-induced situation, the risk automatically
becomes high and an intervention for removal is required. This pushes the decision
tree to the 5th level, risk management. Under this situation, no additional aid from
outside sources would be required, nor are export permits for samples needed. A
situation report or action plan would be developed and shared with the MGVO
project director and protected area manager.

IMPLICATIONS
One of the deficiencies of historical health data collection systems is that
normally, only data from unhealthy animals was recorded. One benefit of IMPACT
is that it constantly incorporates new data, including that from normal, healthy
individuals, and adjusts baseline prevalence rates accordingly, thus allowing for
assessment of risk to be based on the most up-to-date information available for the
population of concern.
The design of this system has gone through multiple iterations. As its
development progressed, many aspects had to be simplified and definitions made
clear and rigid to be practical. The last major modification was to tier the observation
format into two data collection forms, a basic form completed by trackers, guides and
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researchers, and a complex form completed by health care professionals. This
alleviated the problem of trying to develop one form for all purposes and often failing
to accomplish the intended goals.
Another difficult aspect was developing standardized definitions for each
clinical sign and the criteria to allow an observer to say they had seen enough of a
parameter to call it normal. We realized that perfect definitions do not exist under
field conditions due to vegetation conditions and animal behavior and therefore,
practical but productive definitions were agreed upon.
An example of how the development of this system has changed clinical
approaches is the response to respiratory outbreaks; particularly where multiple
infants are involved. Respiratory disease is responsible for approximately 25% of the
mortality among examined corpses (Nutter et al. 2005). Clinical respiratory
outbreaks are common and usually pose the greatest risk to infants. In the past, even
if an infant died with respiratory signs and other gorillas were showing similar signs,
the dead infant would be left until the mother abandoned it; eliminating the ability to
perform a diagnostic post mortem examination. Now if an infant dies with suspicious
signs of infectious disease and/or other animals are showing signs of clinical illness,
the mother is anesthetized, examined, sampled, and sometimes treated, while the dead
infant is recovered for a thorough post mortem examination. Other animals are often
treated as appropriate, based on the finding of the post mortem examination and
diagnostic samples from the mother.
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Although the system has helped standardize the decision to intervene, there
are still times that human emotion will override the process, such as when a gorilla
received treatment for a naturally occurring wound to the eyelid, causing an unsightly
appearance. This situation should not have warranted an intervention and the wound
should have been left to heal naturally. Authorities, however, requested an
intervention to avoid public criticism and the procedure was successfully completed.
The clinical response decision tree combines data collection methods with a
novel internet based risk analysis system (a part of IMPACT’s function) to direct
implementation of action. With slight modifications, the system also is being used
with a wild chimpanzee population and could be modified for use for other wildlife
populations.
In conclusion, this tool is helping to encourage quick, well-informed,
consistent, rational decision making. The observational data portion of IMPACT will
get more powerful as the observation database builds with ongoing use of the system.
When coupled with a larger contingency plan that includes logistical support for field
activities, public relations and ecotourism activities, it can be a powerful tool for the
conservation of this irreplaceable natural resource. It is my hope that the experience
and knowledge gained by MGVP and its partners in the development of this process
will aid other great ape conservationists in their endeavors. The clinical response
decision tree was the product of a multidisciplinary group of veterinarians,
epidemiologists, and public health professionals with input and consensus from the
other stakeholders of mountain gorilla conservation.
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Table 3.1. The data dictionary of the clinical parameters and signs with severity
ratings for the clinical decision tree of the Mountain Gorilla Veterinary Project.
Severity Rating
Mildly or
Moderately
Abnormal
Thin: a) estimated
<10% loss of weight
b) able to see the
ribs
c) notable muscle
atrophy

Parameter

Clinical Sign

None or
Normal

Body Condition: the
physical state of a
gorilla as
distinguished from
attitude and
behavior

Weight: body
composition in
terms of muscle
mass and body fat

Unable to see the
ribs and muscles
appear normal

Abdomen: part of
the body that lies
between the thorax
and the pelvis

Abdomen extends
beyond the ribs
(convex in
appearance)

Flat (Abdomen and
ribcage form
continuous line)

Sunken: Abdomen
sunken and concave

General Attitude:
The manner of
acting

Age and sex
specific appropriate
behaviors

Behavior not like
rest of the members
at a particular time
of day or in a
particular context.
e.g. lethargy, listless

Performing
severely
inappropriate
behaviors in the
context of the
environment. e.g.
still in the nest after
9 am or at one spot
> 1 hour with no
body manipulation

Manipulation: Any
manual movement
with limbs. e.g.
eating, grooming
etc.

Normal movement
of the limbs of the
body

Unable to perform
normal movements
of any part(s) of one
or more limbs

Unable to perform
normal movements
of any part(s) of
one or more limbs,
high degree of
dysfunction present

Movement: The act
of passing the whole
body from place to
place

Normal movement
of the whole body

Lameness:
Abnormal
movement of one or
more limbs leading
to the individual
limping

Severe Lameness:
unable to keep up
with the group,
abnormal
movement of 1 or
more limbs

Breathing rate:
Frequency of
breathing, recorded
as no. of
breathes/minute

When the observer
visualizes the
nostrils and the
chest and the animal
appears comfortable
and you barely
visualize the
movement of the
chest and there are
no audible sounds

Slow: Breathing
observed as <15
breathes/minute and
audible sounds
may/may not be
heard

Fast: When
breathing is >25
/minute with/
without audible
sounds in a resting
state

Activity: Quality of
being active

Respiratory: relating
to respiration which
is the taking in of
oxygen and
expiration of
oxidation products
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Highly Abnormal
Very thin: a) >10%
loss of body weight
b) ribs obviously
pronounced
c) atrophy of fat,
muscles, sunken
eyes

Table 3.1. (cont.)

Integumentary:
Includes the
epidermis, dermis
and all of their
derivatives i.e. hair,
nails, sebaceous
glands, and
mammary glands

Breathing difficulty:
a problem in
exhalation &
inhalation

No breathing
difficulty shown

Labored: Visible
respiratory effort by
an individual
without respiratory
noise

Extremely Labored:
Visible respiratory
effort by an
individual with
audible respiratory
noise

Coughing quality:
Coughing is sudden
explosive forcing of
air through the
glottis & larynx

No coughing

Dry: Harsh, grating,
short sound with no
mucus production

Productive: Moist
sounding cough
associated with
exudates

Coughing pattern:
The sequence of
coughing

Doesn't interrupt the
activities of an
individual

Continuous:
Coughing >1 time
in 5 minutes And
interrupts the
animal’s activities

Sneezing: Expelling
air from the nose
and mouth by
involuntary
spasmodic
contraction of
muscles of
respiration

One or fewer
episodes of
sneezing per
observation

Periodic:
Intermittent
interruption of the
individuals
activities due to
coughing
Periodic: Episodes
of sneezing that are
isolated events with
periods of >15
minutes between
them

Skin and Hair: The
tough membranous
tissue that forms the
external covering of
the individual and
may have hair
(includes visible
mucous
membranes)

Skin and hair as
expected for the
species

Scaly: Flaky,
whitish looking
pieces of epidermis
sloughing off the
body
Loss of hair:
reduced density of
hair
Other skin/hair
health problems:
rashes, redness,
ulcers , erosions
pustules, nodules
maculae, scars, and
thickenings
Blisters:
collection(s) of fluid
under the epidermis
or within the
epidermis

Extensive or
extreme variations
of Scaly, Blisters,
or Other skin/hair
problems
with/without
pruritis

Wounds: An injury
to any part of the
tissues of the body
caused by trauma or
disease

Intact
Integumentary
System

Cut: Superficial and
limited to the skin
surface
Gash: More than
just skin surface
affected up to the
muscle layer

Severe Gash: More
than skin affected,
muscle and/or
function of a
system impaired
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Continuous: >1
episode of sneezing
within <5 minutes

Table 3.1. (cont.)
Scratching: To rub
to alleviate itching
utilizing nails or
other objects

No scratching or <1
scratch per 30
minutes

Periodic: Scratches
now and then >1
time every 30
minutes

Continuous:
Scratching
occurring >1 time
every 5 minutes or
continuously for >1
minute

Swelling Number:
The number of
swellings on the
individual’s body

None

One: one swelling
on the observed
portion of the body

Many: More than
one swelling on the
observed portion of
the body

Small: Little in size
or extent (< 2.5 cm
in diameter)

Large: (> 2.5 cm in
diameter)

Swelling Size: the
size of any
abnormal
enlargement on any
part of the body

Gastrointestinal:
(feces)

Discharge:
substance that is
emitted or
evacuated as a
secretion

None

Clear, Dried

Bloody, Other
color: white,
yellow, green,
cloudy

Defecation: the
discharge of
excrement from the
rectum

Controlled
elimination

Straining: excessive
effort in excreting
feces from the
rectum

Same as moderate
but continuous

Stool Color: color
of the stool

Brown

Other:
White/yellow, etc

Black- dark colored
stool possibly
indicating blood
from the upper GI
tract
Bloody Red:
Reddish tinge or
flecks of red in the
feces indicating
blood from the
lower GI tract

Stool consistency:
the degree of texture
or viscosity of the
feces

Feces with the
expected
consistency and
discrete lobes

Dry: harder than
normal (lacking
moisture or water)
Other: a mixture of
soft feces and hard
ones or contains
particulates
Soft: No longer
retains its normal
shape but has a
"pudding"
consistency

Watery: stools no
longer retains any
shape or
consistency
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Table 3.1. (cont.)
Other Signs: Signs
other than what is
described above.
e.g. CNS,
Reproductive

Normal movement
and activity

Ataxia and
stumbling,
Hyperactivity and
response

Coma, Paralysis,
Seizures

Prolapsed rectum

Not observed

Observed +/frequently but self
corrects

Permanent
prolapsed, swollen,
maggots

Vomiting

Not observed

Observed once

Frequent vomiting

Dystocia

Not observed

Slow but
progression made

No progression and
female exhausted
and showing signs
of lethargy

EXAMPLES
Central Nervous
System
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Table 3.2. Risk assessment for the Mountain Gorilla Veterinary Project clinical
decision tree by disease diagnosis.
Disease

Morbidity
Mortality
in great apes in great apes

Impact on
Humans

High Risk
Ebola

High

High

High

Other hemorrhagic fevers

High

High

High

Encephalomyocarditis

High

High

Medium

Rabies

Low

High

High

Polio

High

High

High

Shigella

High

High

Low

Mycobacterium tuberculosis

High

High

High

Mycobacterium bovis

High

High

High

Measles

High

High

Low

Strep pneumonia

High

High

Medium

Medium

Low

Medium

Rotavirus

Low

Low

Medium

Respiratory syncytial virus

High

Low

Medium

Monkeypox

High

Low

Medium

Parainfluenza

High

Low

Low

Coronavirus

Low

Low

Low

Salmonella

Low

Low

Low

Campylobacter

Low

Low

Low

Sarcoptes

Medium

Low

Low

Entamoeba coli

Medium

Low

Low

Microsporum

Medium

Low

Low

High

Low

Low

Medium Risk
Entamoeba histolytica

Low Risk

Mycoplasma pneumonia
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Table 3.3. Outbreak risk assessment for the Mountain Gorilla Veterinary Project
clinical decision tree by Clinical Signs.
Risk Category

Description

Low

1 dead with no clinical signs of infectious disease and no other animals
with clinical signs of infectious disease
1 dead with no clinical signs of infectious disease and 1 or more
individuals with mild or moderate clinical signs of infectious disease
No dead and mild or moderate clinical signs in ≤ 8 or ½ of the group size
1 or more individual with infectious disease with an estimated low
transmission rate and low mortality rate

Medium

1 dead with clinical signs of infectious disease
No dead and severe clinical signs in 1-3 animals
No dead and combination of moderate and/or severe clinical signs in 2-4
animals
No dead and mild to moderate clinical signs in ≥ 8 individuals in a group
or ½ of the group size
1 or more individuals with clinical signs of infectious disease with an
estimated low transmission rate but medium to high mortality rate
1 or more individuals with clinical signs of infectious disease with an
estimated medium to high transmission rate and low mortality rate
Combination of clinical signs never before observed regardless of severity

High

>1 dead with clinical signs of infectious disease
No dead and severe clinical signs in >3 animals
No dead and a combination of moderate or severe clinical signs in >4
animals
≥1 dead and severe clinical signs in >1 animal
≥1 dead with a combination of mild to moderate clinical signs in ≥8
individuals or ½ the group size
≥1 gorilla with signs of an infectious disease and an estimated medium to
high transmission rate and medium to high mortality
An infant with severe clinical signs with a mother that has mild to
moderate clinical signs
Suspected high zoonotic potential but unlikely to cause Gorilla mortality
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Figure 3.1. Flow chart of the clinical response decision tree for Mountain Gorillas
(Gorilla beringei). N/A = not applicable, +/- = decision on individual case basis, reg
= regional or in-country veterinarians can handle situation, inter = international help
needed, PA = protected area authority, PD = MGVP project director, PH = Public
health official, SH = stakeholders, S = Subsequent groups, Approp Inst = Appropriate
institution (i.e., NIH, CDC).
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a.

b.

Figure 3.2. Screen capture of the IMPACT personal data assistant data collection
basic observation program showing a) a list of individuals found in the observed
group, and b) the observation of an individual gorilla asking which parameters were
seen and if they were normal or abnormal.
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Your data have been uploaded into IMPACT and analyzed
Date of observation(s): 02/02/04
Group Observed: Sabyinyo
Number of individuals in the group observed: 9 or 100%
Number of individuals in the group not observed: 0 or 0%
Total group size: 9
Number of dead gorillas observed: 0
Number of non-group members observed: 0
Total number of individuals observed: 9
Number of abnormal parameters: 0
Number of individual gorillas with abnormal parameters: 0
Number of new abnormal parameters since yesterday: 0
2-3 days: 0
last week: 0
TRACKER AND GUIDE DETAILED SUMMARY
Number of abnormalities by parameter:
PARAMETERS
NORMALS
Body Condition
9
Activity
9
Respiratory
4
Skin/Hair
4
Discharge – Head
2
Discharge – Other
0
Stool
0
Other System
0

ABNORMALS
0
0
0
0
0
0
0
0

Individuals observed with abnormalities: 0
NAME
PARAMETER(S) ABNORMAL
None
None
Comments:
GORILLA
None
ACTION TO BE TAKEN:

COMMENTS
None
None

Figure 3.3. Example IMPACT summary report from a Level 1 routine observation
with no abnormal parameters.
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Your data have been uploaded into IMPACT and analyzed
Date of observation(s): 02/02/04
Group Observed: Sabyinyo
Number of individuals in the group observed: 9 or 100%
Number of individuals in the group not observed: 0 or 0%
Total group size: 9
Number of dead gorillas observed: 0
Number of non-group members observed: 0
Total number of individuals observed: 9
Number of abnormal parameters: 2
Number of individual gorillas with abnormal parameters: 2
Number of new abnormal parameters since yesterday: 2
2-3 days: 2
last week: 2
TRACKER AND GUIDE DETAILED SUMMARY

Number of abnormalities by parameters:
PARAMETERS
NORMALS
Body Condition
9
Activity
9
Respiratory
4
Skin/Hair
4
Discharge – Head
2
Discharge – Other
0
Stool
0
Other System
0

ABNORMALS
0
0
1
1
0
0
0
0

Individuals observed with abnormalities:
NAME
PARAMETER(S) ABNORMAL
Kabatwa
Respiratory
Turiho
Skin/Hair
Comments:
GORILLA
Kabatwa
Turiho

COMMENTS
Coughing a lot
Cut on left wrist

ACTION TO BE TAKEN: Conduct intensified observation and more complex data
collection and review.
Figure 3.4. Example IMPACT summary report for a Level 1 routine observation with
abnormal parameters.
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a.

b.

Figure 3.5. Screen capture of the IMPACT personal data assistant data collection
intensive observation program showing a) the observation of an individual gorilla
asking which parameters were seen and if they were normal or abnormal, and b) the
specific clinical signs for the body condition of the observed individual.
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Your data have been uploaded into IMPACT and analyzed
Date of observation(s): 04/02/04
Group Observed: Sabyinyo
Number of individuals in the group observed: 9 or 100%
Number of individuals in the group not observed: 0 or 0%
Total group size: 9
Number of dead gorillas observed: 0
Number of dead gorillas with clinical signs of infection: 0
Number of dead gorillas without clinical signs of infection: 0
Number of non-group members observed: 0
Total number of individuals observed: 9
Number of abnormal clinical signs: 5
Number of individual gorillas with abnormal clinical signs: 3
Number of mild or moderate abnormalities: 5
Number of mild or moderate infectious abnormalities: 2
Number of mild or moderate noninfectious abnormalities: 1
Number of mild or moderate undetermined (+/-) abnormalities: 2
Number of severe abnormalities: 0
Number of severe infectious abnormalities: 0
Number of severe noninfectious abnormalities: 0
Number of severe undetermined (+/-) abnormalities: 0
Number of new abnormal clinical signs since yesterday: 1
2-3 days: 2
last week: 3
Number of new mild or moderate abnormalities since yesterday: 1
2-3 days: 2
last week: 3
Number of new severe abnormalities since yesterday: 0
2-3 days: 0
last week: 0
Estimated Transmission Rate for this group is HIGH
Estimated Mortality Rate for this group is LOW
Figure 3.6. Example IMPACT summary report from a level 2 intensified observation
as a follow-up to the routine observation of Sabinyo group (Figure 3.4) where two
individuals were observed with abnormal parameters that have not resolved, and
additional cases were observed thereby indicating an outbreak situation.
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THIS GROUP IS PROBABLY IN AN OUTBREAK
IF IT IS IN AN OUTBREAK THE RISK LEVEL FOR THIS GROUP IS MEDIUM
Action to be taken: Continue Observation, Alert Protected Area Manager and Project
Director
VETERINARIAN DETAILED SUMMARY
Number of abnormalities by parameter:
PARAMETER
SEVERE
Body Condition
Activity
Respiratory
Skin/Hair
Discharge – Head
Discharge – Other
Stool
Other System

NORMAL

MILD or MODERATE

9
9
7
8
7
9
2
0

0
0
2
1
2
0
0
0

Individuals observed with abnormalities:
NAME
PARAMETER (S) ABNORMAL
Turiho
Skin/Hair
Guhonda
Respiratory, Discharge - Head
Kabatwa
Respiratory, Discharge – Head
Comments:
GORILLA
Turiho
Guhonda
Kabatwa

COMMENTS
Wound healing well, using hand normally
Continuous productive coughing
Continuous productive coughing

Figure 3.6 (cont.).
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0
0
0
0
0
0
0
0

CHAPTER IV
EVALUATION OF A CLINICAL DECISION TREE FOR THE MOUNTAIN
GORILLA

ABSTRACT
A syndromic surveillance system was developed by the Mountain Gorilla
Veterinary Project (MGVP) to collect standardized data on a consistent basis to
understand the ecology of disease within this highly endangered species. The system
is based on a hierarchical decision tree where trackers and guides observe animals
daily for abnormalities. When abnormalities are observed, MGVP veterinarians
verify any abnormalities using standard clinical signs. The decision tree is predicated
on the assumption that the trackers and guides and the veterinarians can conduct
observations in the same standard fashion. This study demonstrates that the
percentage of a group observed on any observation varies with group size and
whether a veterinarian or tracker and guide conducted the observation. The
probability of observing any individual gorilla varies with the size of the group,
observer type and gender/age class of the individual. Adult and subadult females,
juveniles, and subadult males tend to be observed less than expected, whereas adult
males (silverbacks) and infants tend to be observed more than expected. When
individual gorillas are observed, the 7 parameters used to assess gorilla health vary
with observer type. This indicates that training for both the veterinarians and trackers
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and guides conducting observations needs to be provided to adjust observation habits.
The data suggest that the reactionary observation of the veterinarians to problems
detected by the trackers and guides may bias their observation to specific gender/age
classes and reduce the number of individuals seen. It is recommended that longer
observation periods be conducted, the validity and reliability of the observation be
verified, and that trackers and guides conduct observations on the same day as
veterinarians to obtain the most complete information. This paper provides the first
attempt to evaluate a syndromic surveillance system to monitor health of mountain
gorillas to identify emerging threats.
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INTRODUCTION
Mountain gorillas (Gorilla beringei beringei) are a highly endangered subspecies of great apes. The range of mountain gorillas is confined within Rwanda,
Democratic Republic of Congo and Uganda (Butynski and Kalina 1993). It has been
recognized from experiences with great apes in captivity and limited data from wild
populations that the potential introduction of diseases from the human population and
domestic animals to the mountain gorilla is one of the greatest threats to their longterm viability. Gorillas share >97% of their genetic make-up with humans (Sibley
and Ahlquist 1984, Hacia 2001), making them susceptible to many diseases from
humans (Butynski and Kalina 1998). Due to conservation practices and the growing
eco-tourism, many groups of free ranging gorillas have been habituated to humans
(Butynski et al. 1990, Butynski and Kalina 1993). The increase in interactions
between the gorillas and man can facilitate transfer of anthropozoonotic pathogens
(Ashford, et al. 1990, Ashford, et al. 1996, Hastings, et al. 1992, and Mwebe 1998),
which can lead to occurrence of disease.
The popularity of tourism has brought enormous international interest to the
gorillas. This same eco-tourism innovation that has been used to protect the gorillas
has led to increased gorilla exposure to people from all over the world, bringing
potential carriers of diseases within sneezing distance of the gorillas on a daily basis.
Yet, so little is known about the risks this has created for these unique animals
(Butynski and Kalina 1998). Disease is one of the factors that could lead to a
population crash (Butynski 1990). In protected areas (i.e., conservation areas and
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national parks) where deforestation and bush meat practices are a lesser threat, disease is
rated as the number one threat to mountain gorilla survival.
Currently, the Mountain Gorilla Veterinary Project (MGVP) and
governmental conservation veterinarians monitor the health of the gorilla populations
by observation, non-invasive biological sampling, and post-mortem examination.
Access to biological samples is limited to invasive collection during interventions for
life-threatening problems and available archived material. Because of this limitation
of physical contact with the animals, an intervention policy using clinical signs
obtained during routine observation was developed (Chapter 3, MGVP Decision Tree
Writing Group In Press).
The clinical decision tree was conceptualized with input from various
stakeholders including field staff. It outlines how a health and/or management action
is triggered through the identification and assessment of the number and severity of
clinical parameters and signs (Chapter 3, MGVP Decision Tree Writing Group In
Press). The foundation of the decision tree is daily clinical observations. Daily
clinical observations record whether the individual gorillas were observed or not, and
the observation of normality and abnormality within 7 different designated body
parameters. The system was piloted by MGVP veterinarians (Rwego 2004) to ensure
that clinical parameters and signs could be observed in the wild. Daily clinical
observations are currently restricted to one hour, the time allotment for a tourist
visitation. The decision tree is multi-tiered, with the base tier being the daily
observations of trackers and guides. The second tier is a more comprehensive
observation by veterinarians when the opportunity arises and an individual gorilla is
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deemed in need of medical examination. The overall objective of this study was to
evaluate select elements of the clinical decision tree of MGVP to determine the
overall effectiveness for monitoring gorilla health using this multi-tiered approach.

METHODS
The clinical signs were recorded on a form developed by Mountain Gorilla
Veterinary Project (MGVP) with input from other Non-Governmental Organizations
(NGO) and Protected Area managers at an International Gorilla Conservation
Program (IGCP) regional meeting. The definitions for clinical parameters and signs
used in this study are taken from the MGVP decision tree writing group (2005)
(Chapter 3). An electronic version of the data form was created for use on Personal
Data Assistants (PDA).
The All Occurrence Sampling method was used (Martin and Bateson 1998) to
record any clinical parameters observed in all the gorillas in the group. Observing all
the gorillas isn’t always possible during the one hour visitation period, though as
many as possible are observed during this period of time. During the visitation
period, the gorillas seen and not seen are noted, and clinical parameters observed
(body condition, activity, respiration, integument (skin/hair), discharge from the head,
discharge other, and stool) and their status (normal/abnormal) recorded. In All
Occurrences Sampling (AOS) method the occurrence or non-occurrence of certain
types of easily observed behaviors are for every individual observed (Martin and
Bateson 1998).

95

The number of individuals observed was documented to provide the
denominator for estimation of prevalence rates. The number of individuals observed
is compared to the entire group to determine how representative observed individuals
are in terms of age and gender distribution relative to the entire group. Age groups
were defined as infant, juvenile, subadult, and adult. Gender classes could not be
determined for infant and juvenile.
Data collection commenced when the observer visiting the gorillas first
encountered the gorilla group. After the day-specific data were recorded (e.g.,
number and type of people viewing the gorillas, altitude, location, time of day, etc)
the observer would locate and identify individual gorillas and begin recording
specific data. For each gorilla, 7 parameters were chosen for observation (Table 3.1).
All parameters were strictly defined in a data dictionary (MGVP Clinical Decision
Tree Group In Press, Table 3.1). The observer recorded which parameters and/or
signs they adequately observed for that individual gorilla.
The clinical decision tree is a multi-tiered system with observations being
conducted by trackers and guides or veterinarians (MGVP Clinical Decision Tree
Group In Press, Chapter 3). Therefore, some observations in the system are
conducted at the tracker/guide level, whereas others are at the veterinarian level. The
main difference between the two observations is the level of detail observed. The
designated leader of the trackers and guides observe individual gorillas to the level of
the parameter (i.e., body condition, respiratory, skin/hair, etc.), whereas the
veterinarians provide detail to the clinical sign level (sunken abdomen in body
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condition, hair loss in skin/hair, etc.). Although the phrase “trackers and guides” is
used, it denotes a single individual from this group conducting an observation.
Extensive training on the identification, classification, and recording of
clinical signs was conducted with the trackers and guides to ensure consistency in
observation data. The field veterinarians were trained as a group by long-term field
veterinarians and researchers with extensive field experience. These field
veterinarians were then used to train the trackers and guides within their respective
regions. Standardized training materials were developed for use in all training
sessions.
Individual gorillas were recorded as seen and then, any parameters seen were
recorded. As individual gorillas are often mobile during the observation period, an
individual would be followed so that the observer could attempt to complete an
observation (defined as observing all listed parameters); whereas at other times,
depending on how practical it was to follow the gorillas, the observer remained
stationary and recorded information on gorillas as they passed in and out of sight.
Thus, during an observation period, individual animals were either seen or not, and if
seen, clinical parameters and signs of each individual were observed or not. Of
interest is the detection rate of individuals, as well as, the observability of each
clinical sign, given the animal was observed.
Detection rates were modeled as a logistic regression using a logit link
function in SAS (SAS Institute, Inc., version 9.1) Proc GLIMMIX and Proc
GENMOD. Type of observer (tracker and guide/veterinarian) and gender/age class of
gorilla were treated as fixed effects and group and individual were modeled as
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random effects. Chi-square contingency tables were used to discern differences
among levels within main effects of the logistic model. Pearson correlations were
used to examine association between variables. Alpha of 0.05 was chosen for all
analyses.

RESULTS
Two hundred twenty three observations were obtained on mountain gorilla
groups from 2002-2005. Observations were conducted in Bwindi Impenetrable
Forest National Park in Uganda (n= 210) and Parc de National de Virungas in
Rwanda (n= 13). Ten different gorilla groups were observed during this study (Table
4.1). Numbers of total observations per group during the study period ranged from 1
to 121. A total of 132 different gorillas were observed. Veterinarians conducted 99
observations, while trackers and guides 124. Observations were approximately one
hour in duration.
The average group size for observed gorilla groups was 17.1 individuals, with
a range of 6 to 38.25 (Table 4.1). During an average observation, 65.5% of the
individuals in a group were observed (Table 4.1). The proportion of the group
observed was influenced by group size (χ21 = 98.98, P<0.001) and whether the
observer was a veterinarian or tracker/guide (χ21 = 35.30, P<0.001). The model
parameter estimates indicated that trackers and guides saw more of the group during
an observation than did the veterinarians and the proportion of the group observed
declined with group size (Table 4.2, Figure 4.1). The rate of decline was greater in
veterinarians than in trackers and guides (χ21 = 10.10, P<0.001). A chi-square
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analysis corroborated that trackers and guides observed more individuals per
observation than did veterinarians (χ21 = 247.7, P<0.001).
Group size (F1,3033 = 10.27, P=0.0014), gender/age class (F6,3033 = 3.46,
P=0.0020), and observer type (F1,3033 = 10.33, P=0.0013) main effects all influenced
the probability of an individual being observed. A significant interaction was
observed between gender/age class and observer type (F4,3033 =7.64, P<0.001). The
model parameter estimates indicated that trackers and guides are more likely to
observe an individual than a veterinarian and that observability of an individual
decreases with group size. Plots of the probability of observing an individual of a
gender/age class by either a veterinarian (Figure 4.2a) or a tracker/guide (Figure 4.2b)
illustrate the different observation probabilities between the two groups. The range
of variation in observability increased dramatically as group size increased (Figure
4.3).
Across all observers, juveniles, adult and subadult females, and subadult
males were observed less than expected, whereas adult males and infants were
observed more than expected (χ26 =247.8, P<0.001). Within the observations of
trackers and guides, both adult males and females were seen more than expected,
whereas juveniles and subadults were seen less than expected (χ25 =122.5, P<0.001).
Within the observations of the veterinarians, adult and subadult females were
observed less than expected, whereas adult and subadult males were observed more
than expected (χ25 =140.9, P<0.001).
For those animals that were observed, the observability of the parameter body
condition was influenced by whether the observer was a veterinarian or tracker/guide
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(F1,1751 = 48.48, P<0.001) (Figure 4.4). Body condition was observed less often by
the veterinarians than the trackers and guides. Trackers and guides observed the body
condition of adult males and infants more than expected whereas they observed adult
female body condition less than expected (χ25 =25.621, P<0.001). Veterinarians did
not show observation bias to any gender/age class on body condition (χ25 =2.952,
P=0.707). Although graphically it seems that infants are observed less frequently
than the other groups, the variation around estimates are very large (Figure 4.5).
The observability of the parameter of activity was not influenced by group
size or gender/age class of the individual, but was influenced by observer type (F1,1748
=13.28, P=0.0003) (Figure 4.6). Trackers and guides (χ25 =10.376, P=0.065) and
veterinarians (χ25 =1.706, P=0.888) did not show observation bias to any gender/age
class on the activity parameter. Although graphically veterinarians appear to observe
infants less often than other gender/age classes, the variability around the estimates
are large and estimates, therefore, not different (Figure 4.7).
The observability of the parameter of respiration was not influenced by group
size (F1,1746 = 1.12, P=0.2910), gender/age class (F6,1746 = 0.70, P=0.6491) or observer
type (F1,1746 = 0.60, P=0.4393)(Figure 4.8). The parameter was observed slightly
more often by the veterinarians than the trackers and guides. Examined alone,
trackers and guides observed the respiratory parameter more often than expected in
adult males and infants, but less often in the other gender/age classes (χ25 =11.427,
P=0.040). Veterinarians did not show observation bias to any gender/age class on
respiration (χ25 =4.748, P=0.447); however, infants and adult females are predicted to
be observed least often (Figure 4.8).
100

The observation of the integument parameter did not vary with group size
(F1,1691 =0.42, P=0.5180), the type of observation (F1,1691 =1.46, P=0.2267), or the
gender/age class of the individual (F6,1691 =1.83, P=0.090) (Figure 4.9). Although the
range of observability of the integument parameter was limited, the model predicts
veterinarians to observe infants consistently less often than the other gender/age
classes (Figure 4.9), though the differences are not significant (Figure 4.10).
The observation of discharge from the head was influenced by the observation
type (F1,1751 =31.06, P<0.0001). The parameter was observed more often by
veterinarians than trackers and guides, with tracker and guide observability dropping
off more sharply at larger groups sizes (Figure 4.11). The range of variability in
tracker and guide observations increased as group size increased (Figure 4.13).
Trackers and guides observed adult females, infants, and adult males more than
expected while juveniles and subadult males were observed less than expected (χ25
=20.065, P=0.001). Veterinarians did not show observation bias to any gender/age
class on discharge from the head (χ25 =6.157, P=0.291).
Due to the limited number of observations of the parameter, the random
effects of individuals within group could not be included in the model of discharge
from parts other than the head (discharge other, henceforth). Because of this, the
interaction of observer type with gender/age class could not be examined. Trackers
and guides were more likely to observe the parameter of discharge-other than
veterinarians (F1,1752 = 83.22, P<0.001) (Figure 4.13). Gender/age class did not effect
observability of discharge-other (F6,1752 = 0.71, P=0.6440) (Figure 4.14). Trackers and
guides observed this parameter more than expected on adult males and less than
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expected on all other gender/age classes (χ25 =26.434, P<0.001). When veterinarians
did observe this parameter, they did not show bias to any gender/age class (χ25
=4.463, P=0.483).
Due to the limited number of observations of the parameter of stool, the
random effects of individuals within group could not be included in the model.
Because of this, the interaction of observer type with gender/age class could not be
examined. The observation of the stool parameter was influenced by the observer
type (F1,1752 =11.90, P<0.001) and gender/age class of the individual (F6,1752 =12.32,
P<0.001). Trackers and guides were more likely to observe this parameter than
veterinarians (Figure 4.15). Adult males were more likely to be observed whereas
infants less likely (Figure 4.16). Care must be taken in interpretation of this estimate,
however, even though the model did converge, the goodness of fit criterion of
deviance indicate that the model may not be adequate (value/df = 0.50). Trackers
and guides observed adult male stool more than expected and infants, juveniles, and
adult females less than expected (χ25 =88.670, P<0.001); whereas veterinarians did
not show observer bias to any gender/age class (χ25 =4.567, P=0.471).

DISCUSSION
The syndromic surveillance system is predicated on the assumption that
individual gorillas within groups and clinical signs are equally observable across
groups and individuals. This study indicated that attributes of the individual gorilla,
the gorilla group, and the observer influenced observability of individuals and clinic
signs. During this study, percentage of the group observed was influenced by group
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size and type of observer. As the group size increased, the limitation of a one hour
observation made it more difficult to adequately observe each of the gorillas for
overall health. Figure 4.1 indicates that a group size of 20-25 individuals would only
have about ½ of the group observed. Thus, a longer time period may be required for
veterinarians and trackers and guides to make an adequate observation on the whole
group.
Trackers and guides differed from veterinarians in their ability to observe the
entire group. It is not unexpected that the trackers and guides would observe more
individuals in a single observation compared to veterinarians. The veterinarians are
often conducting observations to verify some abnormality identified by the trackers
and guides the previous day. Thus, the veterinarians are more focused on observing
an individual gorilla rather than observing the entire group. Additionally, the
veterinarians are not as familiar with the individuals as the trackers and guides and
may require assistance for identification purposes. Finally, the veterinarians are
conducting more detailed observation using the complex form. All of these factors
hinder the veterinarian’s ability to observe the same number of individuals as the
trackers and guides. Another possible explanation is that trackers and guides are
overestimating the number of individuals they observe. It might be recommended
that the trackers and guides conduct an observation on the same day as the
veterinarian to maintain the greatest amount of information for the group.
Group size, the type of observer, and gender/age class of the individual
significantly affected the observability of an individual gorilla. This can have
significant ramifications for a syndromic surveillance system. Adult and subadult
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females tended to be observed less than expected across all observations. In a
population with such low numbers as the mountain gorilla, the female and infant
portion of the population becomes especially important. The current methodology of
conducting an observation may cause this discrepancy in observation of these classes
of individuals as adult females tend to be more secretive, especially when they have
new born infants.
When examined by observer type, the trackers and guides tended to under
observe the juveniles and subadults. Thus, it is the veterinarian observation that
under observes the female population. This points to the need for a more structured
approach to conducting an observation. Watts (1996) determined that mountain
gorillas maintain a social structure that influences the distribution of the group in
space. He noted that adult females and young tended to be more closely associated
with the adult males for protection. Thus, the observations of the trackers and guides
tend to follow this pattern of gender/age class distribution. By entering the “center”
of the group around the adult male, they observe the gender/age classes most closely
guarded.
Differences in observability may also impact ecotourism by what gender/age
classes tourists are able to see. If adult females with infants are less visible, does this
affect the tourists’ attitudes of seeing the gorillas? Researchers may be interested in
determining the expectations of tourists to provide customer satisfaction.
The probability of observing the 7 parameters of body condition, activity,
respiration, integument, discharge from the head, discharge other, and stool that are
used as the measures of animal health varied mostly by observer type. The
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probability of observing the parameters body condition, activity, respiration,
integument, and discharge from the head across group size, were observed on average
50% of the time or more regardless of the observer type (Figures 4.4, 4.6, 4.8, and
4.11, respectively). If observing half of the individuals during an average observation
is acceptable, then any statistical difference attributed to differences of observer type
would be negligible. The respiration and discharge from the head parameters,
however, were predicted to decline precipitously at larger group sizes (Figures 4.8
and 4.11). Because respiratory diseases are one of the most common problems in the
gorillas (Nutter et. al. 2005) and this parameter points to signs of respiratory
problems, observers may need to be encouraged to watch more closely for this
parameter.
Within the tracker and guide observations, the gender/age classes were often
observed disproportionately more than expected. Veterinarians tended to show little
bias towards gender/age classes in an observation. Trackers and guides tended to
observe the discharge head more than expected in infants, adult females and adult
males. Similarly, trackers and guides tended to observe the respiratory parameter
more than expected in infants and adult males. From a health standpoint, respiratory
diseases are one of the leading causes of mortality in infants (Nutter et. al. 2005).
The fact that the trackers and guides over observed these parameters in the infant
population is encouraging. However, the respiratory parameter of adult females is
still observed less than expected and several parameters are observed seldom at larger
group sizes. The training of the trackers and guides is standardized to the extent
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possible, however, it may need to be stressed during the training to be more diligent
on the observation of some parameters.
This study assumes that there is validity and reliability in the observations
under consideration. A study is currently underway with MGVP, the Uganda
Wildlife Authority, and the Wildlife and Animal Research and Management Unit at
Makerere University to assess validity and reliability of the clinical decision tree.
The study will aid in determining the quality and consistency of the tracker and guide
data in terms of ability to detect individuals, observability of each of the parameters,
and correspondence to the observation of a veterinarian and other trackers and guides.
In sum, results from this study indicate that longer time periods are needed for
observations. Additionally, there appears to be differences in the observations
conducted by veterinarians versus the trackers and guides. This may be a function of
the reactionary nature of the veterinarians to an abnormality detected by the trackers
and guides. The veterinarians are specifically looking for a single gorilla to examine
some health issue, while the trackers and guides are conducting a general survey of
the group, irrespective of an individual abnormality. It may be necessary for trackers
and guides to conduct observations even on the days that veterinarians collect data.
This would provide consistent data with previous observations and a more complete
assessment of the entire group for that day.
No assessment of the observation of abnormalities could be conducted at this
time. Currently, none of the tracker and guide observations indicated any
abnormalities in the gorillas. The validity study currently underway should determine
if any disparities in detection of abnormalities between trackers and guides and
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veterinarians exist. Additionally, data will need to be collected during an outbreak
situation to determine any associations between the 7 parameters and disease. Once
the clinical decision tree is validated, a year of data collection is needed to establish
the first annual baseline of information for the gorillas. This dataset will allow us to
develop seasonal epidemiological profiles of parameters for the species. It is
recommended to revisit the issues raised in this study after modifications to the
system are implemented. This first attempt to use and test a syndromic surveillance
system on mountain gorillas as an indicator of health demonstrates proof of concept
but also identifies sources of variability and opportunities to improve disease
surveillance in mountain gorillas.
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Table 4.1. Mountain gorilla groups observed in Rwanda and Uganda, 2002-2005,
with the average group size and mean, minimum, and maximum percentage of group
observed during each observation.
Group Name

Observation
Days
1

Mean %
Observed
70.4

Max %
Observed
77.8

Min %
Observed
66.7

Avg. Group
Size
13.0

13

3

30.8

30.8

30.8

9.0

H

1

83.3

83.3

83.3

6.0

Habinyanja

15

54.8

100.0

22.7

22.0

Kyagurilo

36

93.3

100.0

42.9

14.0

Mubale

21

91.1

100.0

50.0

8.0

Nkuringo

121

56.5

90.5

21.1

19.2

Rushegura

18

79.9

100.0

61.5

13.0

Sabinyo

4

84.1

100.0

72.7

11.0

Susa

4

33.8

50.0

13.2

38.3

223

65.5

Amahoro

TOTAL

110

17.1

Table 4.2. General linear model of the percentage of a mountain gorilla group seen
during a one hour observation in relationship to group size and whether the observer
was a veterinarian or tracker/guide.
Parameter

DF

Estimate

Upper 95% CI

Lower 95% CI

Intercept

1

1.2137

1.1188

1.3086

Group Size

1

-0.0280

-0.0335

-0.0225

Observer Typea

1

-0.4885

-0.6496

-0.3273

Size*Observer

1

0.0143

0.0055

0.0231

a

Observer type was modeled with veterinarians in relation to trackers and guides.
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Figure 4.1. Predicted proportion of a mountain gorilla group observed during a one
hour clinical observation by veterinarians and trackers and guides of Rwanda and
Uganda in relationship to group size.
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Figure 4.2. Predicted probability of an individual mountain gorilla of a specific
gender/age class being observed by (a) veterinarians or (b) trackers and guides in
Rwanda and Uganda. F=female, M=male, U=unknown gender.
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Figure 4.3. Variability of predicted observation of an individual mountain gorilla of
the most and least observed gender/age class by (a) veterinarians or (b) trackers and
guides in Rwanda and Uganda. F=female, M=male.
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Figure 4.4. Predicted probability of the body condition being observed in a mountain
gorilla by (a) veterinarians or (b) trackers and guides in Rwanda and Uganda (note
scale is from 0.4 to 1.0). F=female, M=male, U=unknown gender.
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Figure 4.5. Variability of predicted observation of the body parameter on a mountain
gorilla of the most and least observed gender/age class by (a) veterinarians or (b)
trackers and guides in Rwanda and Uganda. F=female, M=male, U=unknown gender.
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Figure 4.6. Predicted probability of the activity parameter being observed in a
mountain gorilla by (a) veterinarians or (b) trackers and guides in Rwanda and
Uganda (note scale is from 0.5 to 1.0). F=female, M=male, U=unknown gender.
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Figure 4.7. Variability of predicted observation of the activity parameter on a
mountain gorilla of the most and least observed gender/age class by (a) veterinarians
or (b) trackers and guides in Rwanda and Uganda. M=male.
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Figure 4.8. Predicted probability of the respiration parameter of a mountain gorilla of
a specific gender/age class being observed by (a) veterinarians or (b) trackers and
guides in Rwanda and Uganda (note scale is from 0.6 to 1.0). F=female, M=male,
U=unknown gender.
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b. Trackers and Guides
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Figure 4.9. Predicted probability of the integument parameter of a mountain gorilla
of a specific gender/age class being observed by (a) veterinarians or (b) trackers and
guides in Rwanda and Uganda. F=female, M=male, U=unknown gender.
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Figure 4.10. Variability of predicted observation of the integument or skin/hair
parameter on a mountain gorilla of the most and least observed gender/age class by
(a) veterinarians or (b) trackers and guides in Rwanda and Uganda. F=female,
M=male, U=unknown gender.
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Figure 4.11. Predicted probability of the parameter of discharge from the head for a
mountain gorilla of a specific gender/age class being observed by (a) veterinarians or
(b) trackers and guides in Rwanda and Uganda. F=female, M=male, U=unknown
gender.
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Figure 4.12. Variability of predicted observation of the parameter of discharge from
the head for a mountain gorilla of the most and least observed gender/age class by (a)
veterinarians or (b) trackers and guides in Rwanda and Uganda. F=female, M=male.
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Figure 4.13. Predicted probability of the parameter of discharge from parts other than
the head for a mountain gorilla being observed by veterinarians or trackers and guides
in Rwanda and Uganda.
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Figure 4.14. Predicted probability of the parameter of discharge from parts other than
the head for a mountain gorilla of a specific gender/age class being observed in
Rwanda and Uganda (error bars for adult males only are shown). F=female, M=male,
U=unknown gender.
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Figure 4.15. Predicted probability of the parameter of stool for a mountain gorilla
being observed by veterinarians or trackers and guides in Rwanda and Uganda.
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Figure 4.16. Predicted probability of the parameter of stool for a mountain gorilla of
a specific gender/age class being observed by (a) veterinarians or (b) trackers and
guides in Rwanda and Uganda (error bars for adult males and infants are shown).
F=female, M=male.
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CHAPTER V

ASSESSMENT OF PATHOGENS WITHIN THE VIRUNGA MASSIF AND
BWINDI IMPENETRABLE FOREST NATIONAL PARK ECOSYSTEMS

ABSTRACT
The transmission of pathogens from one species to another is common place
throughout the world. More often than not, the transmission is determined to go from
wildlife to domestic species. In some circumstances, however, the reverse is true.
For a highly endangered species such as the mountain gorilla, disease transmission
can be devastating to the entire population. This study examines the pathogen loads
and distributions of species within and surrounding the 2 national parks in Central
Africa that are home to the mountain gorilla. A total of 2492 fecal samples were
extracted from the IMPACT health information system monitoring program. One
thousand seven hundred and ninety six humans, 149 domestic cattle, 248 baboon, 63
rodent, 114 gorilla, and 122 chimpanzee fecal samples were available for analysis.
Of these, 1000 humans, 149 cattle, 140 baboon, and 11 gorilla samples were spatially
referenced. A total of 17 different pathogens were detected within the samples.
Humans had the highest pathogen load with 13 species, followed by cattle and
chimpanzees (11), baboon (10), gorillas (9), and rodents (3). The average number of
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pathogens detected for individuals within each species ranged from 0.13 in rodents to
3.59 in humans. The moment of k for all pathogens was < 1, indicating a relatively
balanced ecosystem. Cryptosporidium, Giardia, and Trichuris in humans were
spatially aggregated, however, the identical spatial distribution of positive values for
Cryptosporidium and Giardia lead the author to question the validity of lab tests.
With the high pathogen load in humans and the potential interaction with the gorillas,
conservationists need to examine the impacts that local people might have on the
species. This research used existing data from multiple studies for analysis. A well
designed study to examine human, gorilla, and other species interactions is needed.
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INTRODUCTION
The transmission of disease from wildlife to domestic animals and humans is
well documented around the world. In the United States, bison (Bison bison) transmit
Brucellosis to cattle (Meyer and Meagher 1995), armadillo (Dasypus novemcintus)
harbor the leprosy bacilli (Truman 2005), and mice carry Hanta virus (Mills et. al.
1999). In Europe, badgers (Meles meles) carry Mycobacterium bovis (Phillips et. al.
2003) and fox rabies (Pastoret and Brochier 1999). In Asia, waterfowl can carry
avian influenza (Martin et. al. 2006). In Africa, many of the native livestock have
been documented to be the source for Foot and Mouth disease (Vosloo et. al. 2002),
Rinderpest (Kimber et. al. 2002), and Heartwater (Neitz 1935); and bats are possibly
sources of the Ebola virus (Leroy et. al. 2005).
In all of these cases, the direction of transmission is from wildlife to domestic
animals. However, disease transmission is not always one direction. Domestic
animals also can introduce disease to wildlife (e.g., Schmitt et. al. 1997, Nielsen et. al.
2000), although frequency is thought to be relatively rare. The issue of disease at the
domestic animal and wildlife interface has become a topic of great concern world
wide (see Gibbs and Bokma 2002).
The mountain gorilla (Gorilla beringei) is one of the most endangered species
in the world. The estimated 740 remaining gorillas occur in two populations in the
protected areas of the Virunga Massif and Bwindi Impenetrable Forest National Park
(Werikhe and Miller 1998). In these protected areas, disease has been determined to be
the greatest threat to the species survival (CBSG 1997). Within the ecosystem of the
mountain gorilla, genetic research has shown that the same species of enteric organisms
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(Giardia spp., Microsporidium spp. and Cryptosporidium spp.) are circulating amongst
humans, cattle, and gorillas (Nizeyi et al. 1999, 2000, 2002).
The human population on the African continent has seen a dramatic increase
since the era of colonization (Kock et. al. 2002). The country of Rwanda has one of the
highest densities on earth with an estimated 423-538 people/km2 (2002 Rwanda Census,
Office National de la Population (ONAPO), Revue du Rwanda sur population et
development, No 38, June 2003). With this burgeoning of people on the continent,
there has been a corresponding increase in the amount of domestic animals also
present (Kock et. al. 2002). This high population of human and domestic livestock
has pushed up to the very borders of the protected areas for the mountain gorillas.
Because of this sharp edge of human and domestic animal activity to the natural
vegetation of the park, there is increased potential for contact with gorillas. In some
areas, gorillas are frequently seen outside the park. Rwego (2004) documented that
nearly half of all observations on the Nkuringo gorilla group were outside the
boundaries of the Bwindi Impenetrable Forest National Park. This occurrence of
gorillas outside of the protected areas increases the potential for disease transmission
among these 3 groups.
One way to assess this transmission potential is by using spatial mapping and
analysis. The objective of spatial mapping and analysis in epidemiology is to
understand the relation between the pathogen of interest, the animal host(s), and the
environment (Koch 2005). Because pathogens and hosts interact within an
environment, understanding their relationship requires understanding the
environment. The idea is that by identifying elements of the relationship, the
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intrusion of dangerous pathogens can be controlled or limited by altering the element
(Done 1985).
Mapping of disease refers to a way of thinking that is inherently ecological.
Mapping assigns relationships between multiple datasets in a manner that permits
these datasets to be considered together in a spatio-temporal context. The cognitive
process of mapping encourages a perspective that is relational and spatial all at once.
Mapping permits us to organize spatial events at scales that best facilitate an
understanding of the phenomena chosen for study. The outcome is an interpretation
of events, of spatial relationships between selected aspects of a dynamic ecology
(Koch 2005).
Gibson et. al. (2002) stated that “overall disease burden is primarily a function
of demography.” While he was referring to the human population and its interactions
with the environment, the same also may be stated for wildlife and domestic animals.
Demography is also a geographic element. Therefore, thinking about disease and
health, we need to simultaneously consider the demographic and ecologic parameters
of the host and pathogen communities and how they interact.
Diseases in wildlife are generally distributed in a negative binomial fashion
(Wilson et. al. 2004). This distribution is an evolutionary trait for long-term
persistence of the pathogen and host species. A negative binomial distribution
indicates that a few of the host species harbors the largest percentage of the pathogen
population. This association is usually termed aggregation. Pathogens in wildlife are
usually highly aggregated within the host population (Shaw and Dobson 1995). The
distribution of those few infected individuals within the host population is often the
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question of interest. Similarly, if the pathogen is not distributed in a negative
binomial distribution, this is an indication of an imbalance in the pathogen-host
relationship. This imbalance can reflect an outbreak going through a natural cycle, or
a perturbation of the system attributable to any number of ecological disturbances
(Munson and Karesh 2002).
Mapping uses classes of discrete events (individuals with disease or sign X) in
the context of potentially relevant data (location, exposure, age, gender) in an attempt
to demonstrate some type of relationship. When events are aggregated at specific
scales (park, group home range, nation) in association with related classes of data
(group interactions, wildlife/domestic interactions, environmental overlap) a
graphically demonstrable conclusion forms that suggests potential critical control
points. The power of mapping is derived from its approach in which location is a
principal attribute of the characterization of events. It is also a graphical way of
thinking that assumes the basic bidirectional thinking of association (Wood 2003). If
events cluster around another object, then the object may have influence on the events
(e.g., John Snow and the water pump). This phenomenon is often referred to as
“structural coupling” (Maturana and Varela 1992).
The objectives of this study were to examine the relationships among the
pathogens harbored by the gorillas, cattle, humans, and other wildlife in the Virunga
Massif and Bwindi Impenetrable Forest National Park, and the potential implications
this relationship has on disease transmission.
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METHODS
Fecal samples and test results were extracted from the health information
system monitoring program IMPACT™ (MGVP, Inc. http://mgvp.cfr.msstate.edu).
Most human and cattle samples had associated GPS locational information, whereas
the gorilla samples were associated with specific groups whose daily locations were
georeferenced. Sample observations were imported into the geographic information
system ArcGIS (version 9.1 ESRI Inc, Redlands California) for analysis. Attached to
each sample location were the test results for fecal analysis.
The aggregation of pathogens within each species was estimated by the
corrected estimate of the moment k (Elliot 1977). For this research aggregation is
defined as the distribution of the pathogen load (number of pathogens/individual)
within the host population or sample (Wilson et. al. 2004). The moment k was
calculated as:
k = (m2-s2/n)/(s2-m)
Where m = sample mean
s2 = sample variance
n= number of samples
Pathogen loads were plotted to examine their frequency distribution.
Pathogens occur in a balanced pathogen host relationship as a negative bionomial
distribution (Shaw and Dobson 1995). Additionally, spatial plots were examined for
clustering of pathogens within an area. Clustering in this research is defined as the
spatial pattern of distribution of samples that are positive for a pathogen (Shaw and
Dobson 1995).
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Sample distribution did not allow for the examination of spatial overlap of
species to the gorillas within any area. Similarly, the limited number of gorilla
samples prevented identification of any interactions among other species. Spatial
clustering was examined for human and cattle samples collected around the Virunga
Massif (Volcanoes National Park) in Rwanda using the Getis-Ord general G (Fortin
and Dale 2005).

RESULTS
A total of 2492 samples were extracted from the IMPACT program (Table
5.1). One thousand seven hundred and ninety six humans, 149 domestic cattle, 248
baboon (Papio hamadryas), 63 rodent, 114 gorilla, and 122 chimpanzee (Pan
troglodytes) samples were available for analysis. Of these, 1000 humans, 149 cattle,
140 baboon, and 11 gorilla samples were spatially referenced (Figures 5.1 and 5.2).
A total of 17 pathogens or pathogen classes were entered into the IMPACT
system. Humans had the most pathogens identified with 13 different listed (Table
5.1). Cattle and chimpanzees had 11, baboons 10, gorillas 9, and rodents 3. The
average number of pathogens detected for individuals within each species ranged
from 0.13 in rodents to 3.59 in humans (Table 5.1). Most pathogens detected in each
species were either shared or had potential to be shared with other species. Several of
the pathogens were identified at the genus, class or super class level, not at the
species level. Prevalence rates of individual pathogens ranged from 0 to 88.4%
(Table 5.2), with humans having consistently greater prevalence rates than the other
species. Gorillas had a high prevalence of the tapeworm Anoplocephalis (88.4%), and
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the roundworm Trichostrongyloid (57.9%). Humans had relatively high prevalence
of Ascarids (63.9%), Trichostrongyloids (54.7%), Nematodirus (41.0%), Trichuris
(69.6%), Cryptosporidium (29.5%), and Giardia (30.6%). Cattle were high in
Eimeria (93.2%), whereas baboons were high in Ascarids (56.0%), Eimeria (59.7%),
Strongyloides (26.2%), and Strongyloidea (31.5%). Chimpanzees had relatively low
prevalence in all organisms, as did the rodents.
The moment k was calculated for all fecal samples for each pathogen
detected. Samples extracted from the system had results presented in several formats.
Some of the samples had results reported in eggs/gram of sample, whereas others
were listed as low, medium or high. Sample results for humans (Figure 5.3), gorillas
(Figure 5.4), and cattle (Figure 5.5) that were reported in eggs/gram were compared.
The moment of k for all pathogens were < 1, as would be expected for a balanced
ecosystem (Figures 5.3-5.5)(Shaw and Dobson 1995). Sample results that were
reported with the ordinal results also were compared. The moment of k was <1,
indicating a negative binomial distribution amongst all the pathogens for all species
with ordinal data (Figures 5.6 – 5.11). The moment of k was < 1 for all ordinally
classified pathogen data (Table 5.3).
The spatial distribution of pathogens within the humans was examined using
the Getis-Ord general G (Fortin and Dale 2005) (Table 5.1). Cryptosporidium and
Giardia were highly clustered in distribution (Gi=0.004, z=16.7, P<0.01 for both)
(Figures 5.12 and 5.13). Both species had exactly the same pattern of distribution
and, subsequently same clustering statistics, calling the results into question.
Trichuris was also clustered in distribution (Gi=0.002, z=2.2, P=0.03) (Figure 5.14).
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All other pathogens in humans were distributed in a spatially random pattern (Table
5.4, Figure 5.15). All pathogens in cattle surrounding the Virunga Massif in Rwanda
were distributed in a spatially random pattern (Table 5.4, Figure 5.16).

DISCUSSION
This study used a series of fecal samples that were collected over a period of
time and across several different research projects. These samples and subsequent test
results were entered into the IMPACT health monitoring system. Information on
distribution of pathogens among individual hosts and across space was extracted and
examined in an attempt to get a better understanding of the distribution and flow of
pathogens within the mountain gorilla ecosystem.
This research found the infection rates of Cryptosporidium and Giardia in cattle
around the 2 gorilla parks to be 12.8 and 16.1%, respectively. This corresponds to the
findings of Nizeyi et. al. (2002) who found prevalence rates of 38% for Cryptosporidium
and 10% for Giardia. Graczyk et al. (2002), found prevalence rates of 2, 5, and 10%
for Giardia in gorillas, humans, and cattle surrounding the Bwindi Impenetrable Forest
National Park in Uganda. These are much less than the 9.1, 30.6, and 16.1% found in
this study. Research by Sleeman et. al. (2000) on parasite loads found in mountain
gorilla in Rwanda more closely associates with the findings in this study. They found
Trichostrongyloides in 97.3% of all gorillas sampled. Prevalence rates of Strongyloides,
Trichuris, and Anoplocephalis were 1.4, 2.7, and 85.1%, respectively. The findings of
this study showed rates of infection at 57.9, 6.1, 113.4, and 88.4% for
Trichostrongyloides, Strongyloides, Trichuris, and Anaplocephalis in the mountain
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gorillas. Ashford et. al. (1996) found prevalence rates of 98, 16, and 89% for
Strongyles, Strongyloides, and Anaplocephalis, respectively, in gorillas in Uganda.
The high numbers of pathogens and high prevalence rates in the humans
sampled within the mountain gorilla ecosystem is alarming. This is especially of
concern when given the number of potentially zoonotic diseases observed. With
disease transmission to the gorillas being one of the greatest concerns for their longterm survival (CBSG 1997), conservationists need to examine the impacts that local
people are having or can have on the species. Often the concern for gorilla health
focuses on the tourists from outside the region who are visiting the gorillas. Although
this is still a major concern, focusing on the local human population also may be very
beneficial to gorilla health. MGVP maintains an employee health program that provides
medical treatment to all personnel who work with the gorilla tourism program
(Mountain Gorilla Veterinary Project 2002 Employee Health Group 2004). Although
annual antihelmenthic treatment is provided to all personnel working with the gorillas,
the high prevalence within the general human population may override the once annual
treatment provided.
It is important to note that many of the pathogens listed within the IMPACT
system are not entered at the species level. Whereas the results indicate that pathogens
are the same within groupings such as strongyloides, these are not classified to the
species level. Many pathogens (at the species level) are host specific. This also points
to limitations of data entered into a system like IMPACT. The hierarchical level of
classification of pathogens must be considered when using data from this type of

138

system. The system may need to require entry of results to a specific taxonomic level of
classification in the future to aid inter-species comparisons.
Cattle are often regarded as the responsible host for the transfer of water borne
pathogens such as Cryptosporidium and Giardia. In this ecosystem, the cattle do not
occur at the headwaters of the ecosystem. The gorilla parks are based around the
volcanoes, and therefore are upstream of any domestic cattle. The transfer to the gorillas
has to be from either gorillas leaving the park and using water sources that cattle use, or
humans or other species are transferring the organisms into the park. It is a well
enforced regulation that all human defecation in the forest be buried.
The very highly clumped distribution of the Cryptosporidium and Giardia and
the identical distributions of the 2 organisms, leads this author to question the validity of
lab results for these two pathogens. Although the distribution for 2 water borne
pathogens could be similar, the clustering of all positives in two areas of the country
with no positives elsewhere is disconcerting. There are 4 possible explanations to this
clumped distribution; 1) the pathogen is truly distributed in this fashion, 2) the samples
were contaminated upon collection, 3) the samples were contaminated after collection
and shipping to the United States, and 4) the laboratory conducting the testing provided
erroneous results. Based on the distributions of other pathogens in the region and the
poor sanitation and water conditions, this author feels the first explanation is not valid.
Thus, conclusions based on the spatial distribution analysis of the Cryptosporidium and
Giardia should be examined with scrutiny. As this research was conducted on existing
sample data and test results, this points to the limitation of such an analysis. A research
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study should be conducted to test the clustered distribution of these organisms, or the
samples should be re-examined if they still exist.
The highly aggregated distribution of samples within the species is a sign of a
relatively healthy association with the host and pathogen (Hudson et. al. 2004).
Pathogens that are spread across a large number of hosts are an indicator of an outbreak
or other system imbalance. The imbalance can be from the introduction of a new
susceptible host with no immunity (or conversely, a new pathogen that local hosts are
naïve to), artificial compaction of a host species, or reduced health condition in the host
species. The fact that nearly all pathogens were highly aggregated is a good sign for the
gorillas.
Aggregation in the host is one aspect of clustering, but pathogens also can
cluster spatially. A combination of aggregated and spatially clustered data points to a
source location for a pathogen and a possible control point to reduce or eliminate the
pathogen. Nearly all the pathogens were not spatially clustered. Only the whipworm
Trichuris was aggregated and spatially clustered (ignoring Cryptosporidium and Giardia
due to the potential problems listed above). Whipworms are fecal-oral transmitted
pathogens that can live asymptomatically in mammals for many years. This study
indicates that further investigation would be required, if Trichuris is a potentially
harmful pathogen to the gorillas, to determine the potential for control.
The observations extracted from the IMPACT system had many problems.
First, most samples had no spatial information by which to georeference their
collection site. Of the 2492 samples from the system, only 1300 were able to be
analyzed in a spatial context. Those 1300 samples were not well distributed across
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the landscape. The samples were fairly clumped and may prevent the detection of
clumped distributions of pathogens on a larger scale. The samples extracted also
were not consistent in the spatial referencing system used. Most of the data were
collected in the Universal Transverse Mercator Projection and World Geodetic
System of 1984 datum. Some 398 of the samples were collected in an unknown
projection and datum and the remaining had no spatial information at all. This points
to the importance of the development of standardized data collection. The IMPACT
system developed for health monitoring for the mountain gorillas encourages the use
of standard spatial data referencing for all samples collected.
The samples in the system had varying degrees of information related to test
results. Whereas these were all fecal samples, several different tests were conducted
on them depending on the original study objective. Immunoflourescent assays were
conducted on most of the samples to detect Cryptosporidium and Giardia species.
All other parasites were detected using floatation and sedimentation techniques. A
number of the samples had been tested a second time with the floatation, once using a
sugar floatation solution the second a salt solution. The results for the sugar solution
were used for this analysis due to discrepancies in the salt solution results. The initial
tests were conducted by the same institution and individual that conducted the IFA
for Cryptosporidium and Giardia. Additionally, visual examination of the data
indicated the second testing provided results that are more similar to results obtained
within country on similar animals (Alecia Lily, Dian Fossey Gorilla Fund
International, unpublished data). Because the data from the salt solution tests and the
IFA show such unusual patterns, this researcher calls to question the validity of these
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results. Because of this, the results from the sugar solution retest are used for the
analysis.
With all of these problems, it was still a very worthwhile venture to conduct
this study. The results from this examination of existing data provide insights into
potential problems for the gorillas. The high prevalence rates of pathogens in the
humans and moderate rates in cattle and baboon point to potential critical control
points for disease transmission. Social behavior in the different primates might
provide clues to pathogen flow.
The analysis also provided insights into short comings of how great ape health
data are currently being collected and entered into such a system for analysis. The
clumped distribution of samples, the lack of sampling within the same area for
multiple species, especially species that overlap with the gorillas, and the limited
sample sizes for the gorillas all were weak points in the study. This does, however,
provide researchers with better understanding of what samples should be examined in
the future. Similarly, at least one species of interest in the gorilla ecosystem was
conspicuously absent. The forest buffalo (Syncerus caffer nanus) roams the forests of
the parks and is often seen in association with domestic cattle. This species is a prime
vessel for the transport of pathogens into the protected areas.
This research points to the need to conduct well designed scientific studies to
examine pathogen distribution and flow patterns. This analysis can provide for
development of hypotheses, but the strength of analysis is limited. A study that can
provide greater insight into pathogen flow between species could be set up such that
samples are collected for each of the gorilla groups on a weekly basis for a 1 year
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time period. The gorillas create new night nests for sleeping every night. Upon
waking and leaving the nest, they tend to urinate and defecate in the nest. Silverbacks
can be identified by the silver colored hairs, nest size, etc. Thus, known individual
silverbacks can be collected. Additional samples of unknown but unique individuals
also can be collected. This would provide an annual baseline of pathogen load for
known individuals (silverbacks) and groups. To supplement this, weekly samples for
known cattle and humans within the region surrounding the gorilla groups would
provide a comparative assessment. Finally, collection of samples of forest buffalo,
baboon, and any other pertinent wildlife species in the home ranges of the gorilla
groups would give a complete picture of pathogens and pathogen flow within the
ecosystem.
The IMPACT system was developed to collect and integrate health data on the
species within the gorilla ecosystem and will help address many of the issues faced in
this study. Data will be collected in a standardized manner with spatial referencing
information attached to the samples. Laboratories will provide test results in more
standardized formats for comparison with other labs. There will still be a need to
develop sound research projects to answer specific questions, such as the issue of
Cryptosporidium and Giardia and their distribution. Study designs should
incorporate all aspects of spatial distribution sampling designs such as sample size,
spatial extent, spatial grain, sampling strategy (i.e. random, stratified, systematic, etc.)
and spatial lag of samples.
The IMPACT system allows for exploratory analysis of data to develop more
research hypotheses and provide more information on how to maintain the valuable
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resource of the mountain gorilla. The system urges individuals to collect data in a
standardized format for comparisons across, as well as, within study projects.
Because disease threats are considered premier to the existence of the mountain
gorilla, studies such as this provide insight into the possible ecological processes that
impact the long-term viability of this valuable wildlife resource.
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Table 5.1. Pathogen loads detected within fecal samples collected within and
around the Virunga Massif and Bwindi Impenetrable Forest National Park in
Rwanda and Uganda.
Species

N
114

Total #
Pathogens
9

Average #
Pathogens
2.07

Gorilla

SE
0.07

# Shared
Pathogens*
9

Humans

1796

13

3.59

0.06

12

Cattle

149

11

2.17

0.09

9

Baboon

248

10

2.18

0.09

10

Chimpanzee

122

11

0.48

0.06

11

Rodent

63

3

0.13

0.05

3

* Identification was not always to the species level. Pathogens identified only to the
genus or family level may be different species.
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Table 5.2. Prevalence (% of samples positive) of pathogens found within fecal
samples collected within and around the Virunga Massif and Bwindi Impenetrable
Forest National Park in Rwanda and Uganda.
Pathogen

Gorilla

Human

Cattle

Baboon

Chimpanzee

Rodent

0.0

63.9

19.6

56.0

10.7

0.0

Trichostrongyloides

57.9

54.7

15.2

0.0

0.0

0.0

Nematodirus

28.7

41.0

4.7

0.0

0.0

0.0

Strongyloides

6.1

5.8

19.6

26.2

10.7

0.0

Strongyloidea

15.9

0.6

0.7

31.5

5.7

0.0

Trichuris

13.4

69.6

12.8

13.3

5.7

0.0

Eimeria Sp.

0.0

0.0

93.2

59.7

1.6

0.0

Taenia

1.2

1.9

0.0

2.0

0.8

0.0

88.4

0.0

0.0

4.4

0.0

0.0

Monezia

0.0

0.0

9.1

0.0

0.0

0.0

Hymenolepsis

0.0

1.1

0.0

0.8

0.8

0.0

Enterobius

0.0

1.1

0.0

0.0

2.5

3.2

Eimeria Leukarti

0.0

0.0

2.7

0.0

0.0

0.0

Cryptosporidium

9.1

29.5

12.8

7.3

1.6

3.2

Echinostoma

0.0

0.2

0.0

0.0

0.0

0.0

Giardia

9.1

30.6

16.1

15.7

6.6

6.3

Microsporidia

0.0

0.8

0.0

0.0

1.6

0.0

Ascaris

Anoplocephalis
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Table 5.3. Measure of aggregation (corrected moment of k) of pathogens found
within fecal samples collected within and around the Virunga Massif and Bwindi
Impenetrable Forest National Park in Rwanda and Uganda.
Pathogen

Gorilla

Human

Cattle

Baboon

Chimpanzee

Rodent

--

0.07

<0.01

0.19

0.11

--

Trichostrongyloides

0.16

0.05

0.28

--

--

--

Nematodirus

0.05

0.01

0.10

--

--

--

Strongyloides

0.05

0.02

0.33

0.08

0.11

--

Strongyloidea

0.16

0.10

<0.01

0.11

0.05

--

Trichuris

0.03

0.07

0.19

0.05

0.05

--

Eimeria Sp.

--

--

0.08

0.18

0.01

--

Tania

--

<0.01

--

0.02

<0.01

--

0.22

--

--

0.01

--

--

Monezia

--

--

0.15

--

--

--

Hymenolepsis

--

<0.01

--

<0.01

<0.01

--

Enterobius

--

<0.01

--

--

0.02

0.02

Eimeria Leukarti

--

--

<0.01

--

--

--

Cryptosporidium

<0.01

0.10

0.03

0.03

0.01

0.03

--

<0.01

--

--

--

--

<0.01

0.08

0.03

0.09

0.03

0.08

--

<0.01

--

--

0.01

--

Ascaris

Anoplocephalis

Echinostoma
Giardia
Microsporidia
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Table 5.4. Getis-Ord G measure of spatial clustering of pathogens found within
human fecal samples collected around the Virunga Massif and Bwindi Impenetrable
Forest National Park in Rwanda and Uganda.
Species

Pathogen

Human

Cattle

Gi

z

p

Ascaris

0.001

-1.2

0.23

Cryptosporidium

0.004

16.7

<0.01

Giardia

0.004

16.7

<0.01

Trichostongyloides

0.002

0.5

0.62

Nematodirus

0.004

1.1

0.27

Strongyloides

0.001

1.7

0.09

Strongyloidea

0.002

0.2

0.84

Trichuris

0.002

2.2

0.03

Tania

0.002

0.1

0.92

Hymenolepsis

0.002

0.02

0.99

Enterobius

0.002

0.02

0.99

Echinostoma

0.002

0.03

0.98

Microsporidium

0.001

0.02

0.99

Ascaris

0.002

0.14

0.88

Cryptosporidium

0.0002

-0.54

0.58

Giardia

0.0003

-0.55

0.58

0.001

0.03

0.96

Nematodirus

0.0004

-0.10

0.92

Strongyloides

0.002

0.44

0.66

Trichuris

0.002

0.32

0.75

Eimeria sp

0.001

-0.42

0.68

Monezia

0.001

-0.24

0.81

Trichostongyloides
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Figure 5.1. Distribution of samples from the IMPACT system around the Virunga Massif regions of Rwanda,
Uganda, and Democratic Republic of Congo.
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Figure 5.2. Distribution of samples from the IMPACT system around the Bwindi Impenetrable Forest National Park,
Uganda.
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Figure 5.3. Pathogen distribution in mountain gorillas (Gorilla beringei) in Rwanda
and Uganda (n=165).
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Figure 5.4. Pathogen distribution in humans around the protected area in Rwanda that
harbor mountain gorillas (n=1000).
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Figure 5.5. Pathogen distribution in cattle around the protected areas in Rwanda and
Uganda that harbor mountain gorillas (n=333).
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Figure 5.6. Categorical pathogen distribution in mountain gorillas (Gorilla beringei) in
Rwanda and Uganda (n=11).
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Figure 5.7. Categorical pathogen distribution in humans around the protected areas in
Rwanda and Uganda that harbor mountain gorillas (n=1796).
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Figure 5.8. Categorical pathogen distribution in cattle around the protected areas in
Rwanda and Uganda that harbor mountain gorillas (n=149).
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Figure 5.9. Categorical pathogen distribution in baboon (Papio hamadryas) around the
protected areas in Rwanda and Uganda that harbor mountain gorillas (n=248).
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Figure 5.9 (cont.).
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Figure 5.10. Categorical pathogen distribution in rodents around the protected areas in
Rwanda and Uganda that harbor mountain gorillas (n=63).
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Figure 5.11. Categorical pathogen distribution in chimpanzees (Pan troglodytes)
around the protected areas in Rwanda and Uganda that harbor mountain gorillas
(n=122).
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Figure 5.12. Highly clustered spatial distribution of Cryptosporidium within human fecal samples collected around the
Virunga Massif (Volcanoes National Park) in Rwanda.
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Figure 5.13. Highly clustered spatial distribution of Giardia within human fecal samples collected around the Virunga
Massif (Volcanoes National Park) in Rwanda.
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Figure 5.14. Clustered spatial distribution of Trichuris within human fecal samples collected around the Virunga Massif
(Volcanoes National Park) in Rwanda.
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Figure 5.15. Nonclustered spatial distribution of Ascaris within human fecal samples collected around the Virunga Massif
(Volcanoes National Park) in Rwanda.
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Figure 5.16. Nonclustered spatial distribution of Trichostrongyloides within cattle fecal samples collected around the
Virunga Massif (Volcanoes National Park) in Rwanda.

CHAPTER VI
CONCLUSIONS
Wildlife health is rapidly becoming an issue of greater global public concern.
Free-ranging wildlife are vectors of important human diseases. Issues such as West
Nile virus in the U.S. and high pathogenic avian influenza virus throughout Europe
and Asia have brought wildlife health to the main stream. Although the relevance of
disease for wildlife populations has been recognized for many years (Leopold 1933,
Carson 1962, Morner 2002), there is increasing understanding within wildlife and
veterinary communities of the role of disease management in conservation and human
health (Meffe 1999). Typically, in popular media coverage of wildlife disease issues,
wildlife are identified as a source of a pathogen that affects either livestock or humans
(Kruse et. al. 2004). Only recently has there been a broader recognition that wildlife
populations may be negatively affected by transmission of diseases from domestic
animals and interactions with humans (Daszak et. al. 2000).
The highly endangered mountain gorilla (Gorilla beringei) is one such species
that has the potential to be impacted by domestic animals and humans. Ironically, the
eco-tourism industry established in the 1970’s to promote awareness and generate
financial support for gorilla conservation also may be one of the greatest threats to
their survival. Hastings et. al. (2000) estimated a near complete devastation of the
gorilla population if the introduction of measles from humans ever occurred. Because
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ecotourism associated with the gorillas has become such a large source of income for
host countries, concern over the health of the animals is high. Disease surveillance is
essential for timely response to outbreaks and delivery of individual-based medical
care. However, in the past, health monitoring and intervention has been haphazard
and arbitrary. A systematic approach has been needed to aid in the monitoring and
surveillance of gorilla health.
The research presented herein laid the foundation for the development and
testing of a health information monitoring system for the mountain gorillas. This
modular, internet-based system is called the Internet-supported Management Program
to Assist Conservation Technologies or IMPACT. The system was designed as a
multi-component, data collection, entry, and management system, built around a
relational database. At the heart of the system is a species database that can
accommodate repeated observations of individual known or unknown animals. This
allows for analysis of health history of individuals, which is important for highly
endangered species such as the mountain gorilla, or population level analysis for
epidemiological monitoring. The system also incorporates spatial locations of
observations to facilitate spatio-temporal analyses within or among species.
Therefore, the system is not limited to epidemiological analysis of individual species,
but is ecosystem oriented.
The component development approach also makes the system expandable.
Under this research, the syndromic surveillance system and sample collection and test
result components were developed and tested. Other modules, including post mortem
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examinations, chemical immobilizations, and behavioral information can and should
be developed in the future.
Development of the initial components of the system was limited by end-user
skill levels and hardware infrastructure. Because the system is used on an
international basis, development must be based around the least common
denominator. In this case, the literacy level of individuals collecting data in the field
may not be that of a professionally trained veterinarian or veterinary technologist.
Those individuals collecting data on the syndromic surveillance system usually have
a very limited education level and often only speak a native language (i.e., Swahili).
Similarly, connection to the internet for an internationally accessible program is
required. Internet connections in the rural portions of Africa are poor at best and nonexistent in many areas. Therefore, the program size, in terms of internet page size,
must be very small to be effective in the field. The IMPACT program has been
designed to operate under these constraints
One objective of program development was to produce a means by which
veterinarians can more objectively provide evidence to the host governments for the
treatment or care for the gorillas. Under the current situation, gorilla researchers and
veterinarians could only provide medical intervention if an individual was in a life
threatening situation. This often could be interpreted as, a) if it is immediately life
threatening or b) some situation that the non-medically oriented governmental
officials have had past experience in understanding the potential threat (i.e., snares
causing gangrenous infection). However, “simple” disease situations such as
respiratory diseases are generally not seen as life threatening, even though the largest
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degree of mortality in infants can be attributed to this class of illness (Nutter et. al.
2005).
Thus, the IMPACT system was designed as a quantitative means of assessing
outbreak situations in the gorillas. With this quantitative assessment, a decision tree
was developed to determine how data should be collected and analyzed to determine
situations where intervention would be required. Development of the decision tree
forced researchers to determine the manner in which data should and could be
collected on the animals. The syndromic system developed uses 7 parameters of the
animal and specific signs within the parameters as indicators of health. Within each
sign, a level of severity also was developed. Although the observation system was
initially designed to be used by trained health personnel; it was decided that the
system had to be simplified for the lay trackers and guides to collect data. This was
required because the veterinarians are not available to conduct daily observations.
Thus, the system was developed as a multi-tiered observation system with the
trackers and guides providing daily observations and veterinarians following up with
more detailed observations when problems were noted.
The system also is designed to help distinguish between outbreak and nonoutbreak conditions. By definition, an outbreak is a disease occurrence in which the
number of cases exceeds that which would normally be expected. The problem with
this definition is there that it requires estimates of normal background levels of
abnormalities in mountain gorillas and this information is limited. Rwego (2004)
conducted 86 observations on mountain gorillas of a single group and provided some
baseline information. His sample size, however, was inadequate to provide seasonal
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and gender/age class specific information. Similarly, the data collected during this
research was too limited to provide annual baseline values. Thus, it is recommended
that a complete year of data be collected for each gorilla group to develop these
baseline rates. Until then, the estimates developed by experienced field veterinarians,
augmented by ongoing monitoring should be used.
With the implementation of any program, training of the users is required. A
detailed training program on the use of the IMPACT was developed. The regional
field veterinarians were trained on the definition of the parameters and signs.
Standardized photos were used to pictorially demonstrate each sign. The regional
veterinarians were then used as the trainers for the trackers and guides within their
region. This was done to ensure each observer or potential observer was trained
using the same material and would be able to identify and classify the parameters and
signs in a consistent manner.
Results from this study indicate that, despite training, the veterinarians and
tracker/guide groups do not observe the gorillas in the same manner. During a typical
observation, the trackers and guides showed a tendency to observe more animals and
more parameters than the veterinarians. The exceptions were the parameters of
respiration and discharge from parts of the body other than the head. Additionally,
the trackers and guides observed the gender/age classes differently than the
veterinarians. Trackers and guides tended to observe gender/age classes in a manner
that coincides with the social structure of the gorillas (Watts 1996).
This research also brought together many years of fecal data collection on the
mountain gorilla, domestic livestock and humans that had occurred in the Virunga
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Massif and Bwindi Impenetrable National Forest areas. The system now includes
fecal sample information from 149 cattle, 248 baboons, 114 gorillas, 122
chimpanzees, 63 rodents, and >1500 humans samples and 146 health observations for
gorilla groups.
Even with all these samples, spatial analysis of differing species within the
same geographic region was not possible. Historically, the data collection for each
species was localized to a very small portion or portions of the region. This very
clearly shows how studies to examine spatial aggregation of parasite or disease across
species and landscapes needs to be conducted within the sampling framework of a
well-designed study. Convenience sampling is not likely to provide the data required
to examine complex spatio-temporal interactions among species. That is not to say
that this combining of data was not a worth while venture. Combing the data
provided evidence that, either Cryptosporidium or Giardia are highly aggregated in
the exact same fashion, or some of the test results from projects are suspect.
Combined results indicated that humans carry the highest pathogen loads of any
species compared in the area. Many of these pathogens are zoonotic with the gorillas.
This points to a need to improve human health care in the vicinity of the gorilla parks
or institute prevention strategies to protect the gorillas. Positive results from the
study indicated that most pathogens are distributed in a negative binomial distribution
within hosts. A negative binomial distribution is a general indication of a healthy
parasite-host relationship (Wilson et. al. 2004).
The combination of these data from disparate research projects does provide
the ability to conduct preliminary analyses and create working hypotheses with which
176

to develop future research. Analyses from these types of data are only preliminary
and do not have strong statistical rigor, and should always be expressed as such. This
system does illustrate how combining multiple data sets of different type can provide
insights into the risk of pathogen flow between species. In the future, the locational
information of the gorilla observations can be combined with the fecal sample results
from individuals within that group to provide additional information regarding
movements of pathogen laden or pathogen free gorillas across the landscape.
Ultimately, the ideal sampling and analysis system would have daily input on
observations of individual gorillas within groups and consistent collection of samples
from each group (with consistent individuals sampled) over time. Coupled with that
would be collection of livestock, wildlife and human samples using a spatial sampling
scheme that is representative of the region within and around the gorilla parks. Such
a sampling design would allow examination of transmission of common pathogens
between species.
It is recommended that the development of IMPACT be continued to include
more comprehensive test results from multiple sample types such as blood, urine, and
tissue. Additionally, modules to incorporate behavioral data, interventions, and postmortem examinations need to be developed. The capabilities to conduct individual
and/or group level analyses needs to be enhanced. Individual assessment of gorillas
and pathogens could be enhanced with the use of polymerase chain reaction (PCR)
technology to ensure differentiation of species/individuals. The ability to incorporate
digital media (i.e., pictures, or video) from observations, samples, and post-mortem
examinations would greatly enhance the ability of researchers in the future to identify
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and detect disease and abnormalities. Additional information that might also
influence animal health would be changes in the vegetation patterns that might impact
carrying capacity of the parks or climate patterns that might influence outbreaks.
Finally, as the amount and quality of data increases within the system, an assessment
of the association of clinical signs to disease diagnosis needs to occur. Development
of predictive models that can rapidly determine disease outbreaks would allow
veterinarians to intervene at earlier stages and possibly prevent an epidemic and loss
of life. The goal of this system is the long-term persistence of this valuable wildlife
species.
An overall system needs to address that health of more than the mountain
gorillas. Livestock and human health are but 2 other arenas that need to be
monitored. Other organizations or Non-governmental Organizations (NGO’s) need to
brought into the area to collaborate with MGVP. The assessment of an ecosystem
and its health is a job far too massive for one organization. Even if the IMPACT
system can handle the data and analyses, MGVP cannot handle the requirements of
all issues beyond those of the gorillas.
Funding for this research was provided by the Morris Animal Foundation, the
Mountain Gorilla Veterinary Project, the Forest and Wildlife Research Center at
Mississippi State University, and the Department of Wildlife and Fisheries at
Mississippi State University.
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